Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1050.Time spend outdoors in summer,49029,0.0997034156073843,0.0403016818307581,0.0207121192190984,0.17869471199567,0.0133702485633072
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1060.Time spent outdoors in winter,45260,0.0117331673128446,0.0456130161155712,-0.0776683442736749,0.101134678899364,0.797001479638082
PLA2G15,Phospholipase A2 group XV,Physical activities,X1070.Time spent watching television (TV),50201,0.23546925774862,0.0400853882636162,0.156901896751933,0.314036618745308,4.30014276867573e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X1080.Time spent using computer,45198,-0.141586687989106,0.0431289034991092,-0.22611933884736,-0.0570540371308517,0.00102920353372273
PLA2G15,Phospholipase A2 group XV,Physical activities,X1090.Time spent driving,44074,-0.155592026087431,0.0450713754630985,-0.243931921995104,-0.067252130179758,0.000557327442859892
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1160.Sleep duration,52014,-0.0426304530731218,0.0372658201779255,-0.115671460621856,0.0304105544756122,0.252651672705992
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34543,0.00361465021794712,0.00914312068509854,-0.014305866324846,0.0215351667607403,0.69259915947229
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34543,0.0204723102923226,0.0089777709859074,0.00287587915994414,0.0380687414247012,0.0226075372715264
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34543,0.0281220013619694,0.0105982696616126,0.00734939282520872,0.0488946098987302,0.0079790975783268
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34543,0.0262505490990961,0.0110164301949981,0.00465834591689992,0.0478427522812923,0.0171963674048648
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34543,0.0320053053496122,0.0112921992690172,0.00987259478233862,0.0541380159168859,0.00460145799305641
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34543,0.0116978434079984,0.0217767363720561,-0.0309845598812316,0.0543802466972283,0.591160303166308
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34543,0.0207097713996385,0.0224265638937364,-0.0232462938320849,0.0646658366313618,0.355794508146359
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34543,0.00166190264624485,0.0157617109912489,-0.0292310508966029,0.0325548561890926,0.916029269288763
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34543,0.021663420808927,0.0116412944554916,-0.00115351632383662,0.0444803579416906,0.0627841018133986
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34543,0.0267253599991222,0.00818965968078837,0.010673627024777,0.0427770929734674,0.00110466837353526
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34543,0.0164784620719748,0.0115958898649187,-0.00624948206326589,0.0392064062072155,0.155328334183394
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34543,0.00466082688461845,0.00665488211161206,-0.00838274205414119,0.0177043958233781,0.48371648130912
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34543,0.00478939881608321,0.00854044728032677,-0.0119498778533572,0.0215286754855237,0.574952355026162
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34543,0.0297307515908633,0.0129076751842481,0.00443170822973693,0.0550297949519896,0.0212788875493618
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34543,0.021373173305416,0.0122544880017854,-0.00264562317808341,0.0453919697889155,0.0811686967868119
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34543,0.0285843659950311,0.0151754758652789,-0.00115956670091552,0.0583282986909777,0.059647670030422
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34543,0.0244637754315055,0.0142642247834183,-0.00349410514399447,0.0524216560070055,0.0863661305771166
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34543,0.0127792738678684,0.0095334631766727,-0.00590631395841005,0.0314648616941469,0.180122715635202
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34543,0.0208262937223316,0.00906465181646867,0.003059576162053,0.0385930112826102,0.0216078894882438
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34543,0.0246173278495221,0.011190890481179,0.00268318250641127,0.046551473192633,0.0278449199631457
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120040.Fatigue severity over the past week,34551,0.229452389787565,0.0645676225701409,0.102899849550088,0.356004930025041,0.000381525734830201
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120041.Waking unrefreshed severity over the past week,34553,0.145048770285597,0.0633373637819135,0.0209075372730463,0.269190003298147,0.0220350197565109
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120042.Cognitive symptoms severity over the past week,34551,0.236940558838856,0.0702472047465402,0.0992560375356368,0.374625080142074,0.000746304877516159
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120098.Mobility problems today,34556,0.421785051167508,0.0789832550610228,0.266977871247904,0.576592231087113,9.4756250916727e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120099.Self-care problems today,34556,0.387961580708881,0.121180874849556,0.150447066003751,0.62547609541401,0.00137110025761332
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120100.Problems doing usual activities,34556,0.182886283026537,0.0736625007164927,0.0385077816222117,0.327264784430863,0.0130521239442735
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120101.Pain or discomfort today,34556,0.126579318756013,0.0646718656977022,-0.00017753801148282,0.25333617552351,0.0503434984659408
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120102.Anxiety or depression today,34556,0.29784509226047,0.0766270644310129,0.147656045975685,0.448034138545256,0.000102127470139593
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120103.Scale to indicate how health is today,34522,-0.0136817515299224,0.00287279024860538,-0.0193124204171889,-0.00805108264265586,1.93699394114079e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34540,0.225985005195687,0.0760675014666906,0.0768927023209731,0.3750773080704,0.0029763972107667
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34525,0.285964442874096,0.0784775492656953,0.132148446313333,0.439780439434859,0.000269811796262492
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34545,0.126304705726191,0.0633966444032367,0.00204728269584663,0.250562128756535,0.0463642998201009
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34547,0.253120527243358,0.064869130462314,0.125977031537222,0.380264022949493,9.59791772798586e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34542,0.237586872670185,0.0790109187321642,0.0827254719551429,0.392448273385227,0.00264442193867028
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120109.Feeling bad about self over the last two weeks,34516,0.162391579159105,0.0808205378350377,0.00398332500243082,0.320799833315779,0.0445319802912568
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120110.Trouble concentrating over the last two weeks,34548,0.235851466395554,0.0814595090570592,0.0761908286437177,0.39551210414739,0.00379537763668999
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34533,0.485234916022933,0.121658156338689,0.246784929599103,0.723684902446763,6.69330664023798e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34479,0.435910351914646,0.157882986604868,0.126459698169104,0.745361005660187,0.00577287497323395
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31503,0.337705607457774,0.0853027331174857,0.170512250547502,0.504898964368046,7.59763832675613e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48951,0.148531812056195,0.0888385621266923,-0.025591769712122,0.322655393824512,0.0945506958053486
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47652,0.0111009454912778,0.0545178491478803,-0.0957540388385676,0.117955929821123,0.838651902616714
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1289.Cooked vegetable intake,50989,-0.208353935800569,0.0385576625648806,-0.283926954427735,-0.132780917173403,6.58306116831452e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50452,-0.325463546223659,0.0414068274608152,-0.406620928046857,-0.244306164400461,3.98153890546557e-15
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1309.Fresh fruit intake,50968,-0.291227130805677,0.041062821411773,-0.371710260772752,-0.210744000838602,1.35200066503314e-12
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1319.Dried fruit intake,49410,-0.288309336895673,0.0437169402340143,-0.373994539754341,-0.202624134037005,4.33816163991457e-11
PLA2G15,Phospholipase A2 group XV,Health and medical history,X134.Number of self-reported cancers,52241,0.296477737521099,0.0852414818463007,0.12940443310235,0.463551041939848,0.000505752515243103
PLA2G15,Phospholipase A2 group XV,Health and medical history,X135.Number of self-reported non-cancer illnesses,52241,0.469099971186769,0.0379567118326009,0.394704815994871,0.543495126378667,5.37186246074707e-35
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X136.Number of operations, self-reported",52241,0.105038172402688,0.0374074153920759,0.0317196382342189,0.178356706571156,0.00498919120065029
PLA2G15,Phospholipase A2 group XV,Health and medical history,X137.Number of treatments or medications taken,52241,0.502877644703525,0.0378923330217763,0.428608671980844,0.577146617426207,4.47692604305302e-40
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1438.Bread intake,51369,0.00701267184386718,0.0018626731521295,0.00336183246569337,0.010663511222041,0.000167000310387592
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1458.Cereal intake,50602,-0.156058455761022,0.039024185419263,-0.232545859182777,-0.0795710523392662,6.37764666131595e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1488.Tea intake,51150,-0.00387127031106815,0.00176902171952334,-0.00733855288133389,-0.000403987740802411,0.028651263014312
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1498.Coffee intake,49892,-0.0915135970181602,0.0391407469722362,-0.168229461083743,-0.0147977329525771,0.0193914262807021
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X1528.Water intake,50221,-0.122133659121358,0.0397570494586914,-0.200057476060393,-0.0442098421823228,0.00212846339826138
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1568.Average weekly red wine intake,43126,-0.294177087347131,0.0455623312619624,-0.383479256620577,-0.204874918073685,1.09647938976364e-10
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43123,-0.0562512697602822,0.0465833731977489,-0.14755468122787,0.0350521417073056,0.22723921509228
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1588.Average weekly beer plus cider intake,43171,0.147955991425784,0.051034949313268,0.0479274907717789,0.247984492079789,0.00374643640022428
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1598.Average weekly spirits intake,43092,0.014640856859305,0.0507204724850601,-0.0847712692114129,0.114052982930023,0.772846417865396
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1608.Average weekly fortified wine intake,43161,0.0524019873772117,0.0928872602931371,-0.129657042797337,0.23446101755176,0.572661249109387
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X1737.Childhood sunburn occasions,45700,0.0100758402437844,0.0447189203092109,-0.0775732435622691,0.0977249240498378,0.821736396734573
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1807.Father's age at death,40789,-0.00764474414255756,0.00253684130736623,-0.0126169531049954,-0.00267253518011974,0.00258644142263024
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1845.Mother's age,40060,-0.00879989129997913,0.00374266042421194,-0.0161355057314345,-0.00146427686852373,0.0187228961053213
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1873.Number of full brothers,51738,-0.00101126495716459,0.0374749999444886,-0.0744622648483623,0.0724397349340331,0.978471846752592
PLA2G15,Phospholipase A2 group XV,Health and medical history,X1883.Number of full sisters,51739,0.0242895975893074,0.0374127570414743,-0.0490394062119823,0.0976186013905971,0.516193114282325
PLA2G15,Phospholipase A2 group XV,Physical measures,X20015.Sitting height,52005,-0.00119817343816856,0.00237103926470457,-0.00584541039698952,0.0034490635206524,0.613326244201459
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20016.Fluid intelligence score,32808,-0.0595815634315059,0.0623196345584494,-0.181728047166067,0.0625649203030549,0.33906572936454
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20018.Prospective memory result,33139,0.0877141756102555,0.0889104866305724,-0.0865503781856663,0.261978729406177,0.323891583185152
PLA2G15,Phospholipase A2 group XV,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32715,0.0109259674210604,0.00333778764574845,0.00438390363539341,0.0174680312067273,0.0010666349626423
PLA2G15,Phospholipase A2 group XV,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32708,0.00652762116458268,0.00331073095851754,3.85884858883001e-05,0.0130166538432771,0.0486800422919737
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20023.Mean time to correctly identify matches,51929,0.00667513766149245,0.0018794227625419,0.00299146904691032,0.0103588062760746,0.000383384073171424
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#1.Illnesses of father_Heart disease,48965,0.00509338207870573,0.0040542746075628,-0.00285299615211736,0.0130397603095288,0.209019190129709
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48544,-0.00146352152403142,0.00920973417721434,-0.0195146005113715,0.0165875574633087,0.873740853942388
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48507,0.00256400442978651,0.0123920328267704,-0.0217243799106835,0.0268523887702565,0.836083814782888
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#12.Illnesses of father_Severe depression,48540,-0.00879569196763615,0.00945188816429436,-0.0273213927696531,0.00973000883438081,0.352082491244177
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48542,-0.00478642276240074,0.00690667605711137,-0.018323507834339,0.00875066230953755,0.488307326198077
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#2.Illnesses of father_Stroke,48707,0.00158749576864057,0.00534171831098892,-0.00888227212089771,0.0120572636581789,0.766325297532075
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48644,-0.00308588039138902,0.00691461432677801,-0.0166385244718739,0.0104667636890959,0.655396152160566
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48545,0.0192355522358069,0.00832703777036828,0.00291455820588513,0.0355565462657288,0.0208957295626389
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48669,0.0197267759504614,0.00659803054877168,0.00679463607486888,0.0326589158260539,0.0027943607241284
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48824,0.0060336873006175,0.00419046246688624,-0.00217961913447953,0.0142469937357145,0.149919010343729
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20107#9.Illnesses of father_Diabetes,48673,0.0136745431386853,0.00571459648854605,0.00247393402113499,0.0248751522562355,0.016722505070784
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50034,-0.00176434302535094,0.00486334531404162,-0.0112964998408725,0.00776781379017063,0.716769303516141
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49906,0.00576342751349996,0.0078497516111298,-0.00962208564431446,0.0211489406713144,0.462822603995443
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49850,0.0101621131576092,0.0164817792271773,-0.0221421741276583,0.0424664004428767,0.537526087907232
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49896,0.0140978853530363,0.00706384360200914,0.00025275189309841,0.0279430188129742,0.0459681572513039
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#2.Illnesses of mother_Stroke,49981,0.0112786449091515,0.00577785189212837,-4.59447994201282e-05,0.0226032346177231,0.050943161485355
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49904,0.0247017693230604,0.00938744008173976,0.00630238676285044,0.0431011518832703,0.00850930621281739
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49879,0.0127961814813928,0.00895543681888566,-0.0047564746836231,0.0303488376464087,0.153052756241516
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49914,-0.0024152412646096,0.00674966451180612,-0.0156445837077496,0.0108141011785304,0.720472459921825
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49919,0.0316442155605563,0.00794499878547938,0.0160720179410167,0.0472164131800958,6.82613489153327e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50133,-0.00289169607410353,0.00383543075154481,-0.0104091403471313,0.00462574819892429,0.450890220348628
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49971,0.0135933889139578,0.00592274277437756,0.00198481307617781,0.0252019647517379,0.0217342989211634
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47168,0.0154131148221081,0.0078352543899405,5.6016217824726e-05,0.0307702134263915,0.0491778485796955
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47055,0.0125533520080801,0.0432365551378731,-0.0721902960621511,0.0972970000783113,0.771557841066753
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47053,-0.0712430782519691,0.0379826949736073,-0.145689160400239,0.00320300389630127,0.0607128813872351
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47142,0.0109030352391896,0.00716744279721775,-0.00314515264335719,0.0249512231217364,0.128225992025482
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47060,0.00413053068051377,0.0242023134189407,-0.04330600362061,0.0515670649816375,0.864487280655737
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47074,0.0141251583059669,0.0135181616342919,-0.0123704384972452,0.0406207551091789,0.296079002756481
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47062,0.00680404410383347,0.018319339319548,-0.0291018609624806,0.0427099491701476,0.71033320041114
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47070,0.018410790520562,0.0160949675009383,-0.013135345781277,0.0499569268224011,0.252683165228245
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47074,-0.00137126327816852,0.01082685609083,-0.0225919012161953,0.0198493746598583,0.899215451063957
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47078,0.0136197310023289,0.0142086615109201,-0.0142292455590745,0.0414687075637322,0.337794815986981
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47262,0.00272658947204365,0.00503405991328771,-0.00714016795800026,0.0125933469020876,0.58807972674316
PLA2G15,Phospholipase A2 group XV,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47154,0.0264587726513486,0.0073789143850375,0.0119961004566751,0.0409214448460221,0.000336827872655205
PLA2G15,Phospholipase A2 group XV,Mental health,X20127.Neuroticism score,46636,0.201809696844475,0.0394170764387524,0.12455222702452,0.279067166664429,3.08260408528926e-07
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32808,0.109085730298276,0.0631698999655355,-0.0147272736341734,0.232898734230726,0.0842269184545075
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20161.Pack years of smoking,31696,0.0404625150153251,0.00396992787742518,0.0326814563755717,0.0482435736550785,3.0405146795431e-24
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31696,0.0385588808383034,0.00371063705484223,0.0312860322108127,0.0458317294657942,3.94784269169502e-25
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20191.Fluid intelligence score,31422,0.0448229103911599,0.0692641999371564,-0.0909349214856666,0.180580742267986,0.517567777211027
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31422,0.144031275463065,0.0705864148404974,0.00568190237568994,0.28238064855044,0.0413356961869637
PLA2G15,Phospholipase A2 group XV,Cognitive function,X20240.Maximum digits remembered correctly,30771,-0.0164955472182536,0.0735385102365535,-0.160631027281898,0.127639932845391,0.82252142240393
PLA2G15,Phospholipase A2 group XV,Physical measures,X20255.Spirometry QC measure,45097,0.0516524542272126,0.0498211123313697,-0.0459969259422721,0.149301834396697,0.299860293944235
PLA2G15,Phospholipase A2 group XV,Eye measures,X20261.avMSE,29977,0.000831974335250878,0.00408925103300498,-0.00718295768943889,0.00884690635994064,0.838786991432498
PLA2G15,Phospholipase A2 group XV,Eye measures,X20262.Myopia diagnosis,29977,0.0119355848009051,0.0939618956030106,-0.172229730580996,0.196100900182806,0.89892415566814
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20280.Glucose-lactate,39875,0.0295379999449477,0.00242597098007624,0.0247830968239982,0.0342929030658971,5.91343889479546e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X20281.Spectrometer-corrected alanine,39909,0.0261243153641212,0.00239694819150293,0.0214262969087754,0.0308223338194669,1.45570534030452e-27
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32673,0.015281786779142,0.0115110202338777,-0.00727981287925834,0.0378433864375423,0.184351668232486
PLA2G15,Phospholipase A2 group XV,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32670,0.0300697444030833,0.0232176737297005,-0.0154368961071298,0.0755763849132964,0.195311721917008
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32668,-0.0217487727145618,0.0254563481501392,-0.0716432150888347,0.0281456696597111,0.392931244031017
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32668,0.013788754790596,0.0111118070509243,-0.00799038702921572,0.0355678966104077,0.214671970988286
PLA2G15,Phospholipase A2 group XV,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32668,-0.00145827818473637,0.0179442372337877,-0.0366289831629602,0.0337124267934874,0.935231292834818
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32675,0.0144239027088428,0.0231071270088987,-0.0308660662285987,0.0597138716462842,0.53250006683841
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32675,0.015899503337665,0.0152687883246335,-0.0140273217786166,0.0458263284539466,0.29776142922565
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32675,0.0152565028359169,0.0167212802239593,-0.0175172064030433,0.0480302120748771,0.361582928507931
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32675,0.0014047981960955,0.0258902279227541,-0.0493400485325025,0.0521496449246935,0.956729418998951
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32675,0.00951611767052071,0.0299379200719212,-0.0491622056704449,0.0681944410114863,0.750597387826648
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32675,0.040245283505925,0.0171893791427477,0.00655410038613939,0.0739364666257106,0.0192395066532865
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32675,0.0403482316568616,0.0290850962195947,-0.0166585569335439,0.0973550202472672,0.165401328716834
PLA2G15,Phospholipase A2 group XV,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32675,-0.0044038691364035,0.0222778911881792,-0.0480685358652348,0.0392607975924278,0.843300853362177
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32678,0.0142810082744604,0.0299181943459464,-0.0443586526435946,0.0729206691925153,0.633135255954295
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32678,0.0374363459285642,0.0147708041963837,0.0084855697036521,0.0663871221534763,0.0112785031043019
PLA2G15,Phospholipase A2 group XV,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32678,-0.026515154178236,0.020542339484358,-0.0667781395675777,0.0137478312111057,0.196822034273223
PLA2G15,Phospholipase A2 group XV,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32678,0.0391824979641355,0.0339014383439938,-0.0272643211900924,0.105629317118363,0.247803754466699
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20600.Liking for adding salt to foods,35433,0.0364587576136032,0.0562083197137705,-0.073709549025387,0.146627064252594,0.516586354243014
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20601.Liking for aniseed,35433,0.0716493338706735,0.0566081590774278,-0.0393026579210849,0.182601325662432,0.205643559807642
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20602.Liking for apple juice,35433,0.0335779795558325,0.0567018389465228,-0.0775576247793522,0.144713583891017,0.553738278117703
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20603.Liking for apples,35433,-0.123309777850861,0.0577431566458076,-0.236486364876644,-0.0101331908250785,0.032742174188447
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20604.Liking for asparagus,35433,-0.213672787506985,0.057694367191646,-0.326753747202611,-0.100591827811359,0.000213610040307625
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20605.Liking for aubergine,35433,-0.232840329309318,0.0565368610893074,-0.34365257704436,-0.122028081574275,3.84197501573414e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20606.Liking for avocados,35433,-0.211321646846704,0.0574748940711235,-0.323972439226106,-0.0986708544673023,0.000237280741616027
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20607.Liking for bacon,35433,-0.102224678902596,0.0572552794831917,-0.214445026689652,0.00999566888445948,0.0742195355826244
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20608.Liking for baked or steamed fish,35433,-0.227283080823243,0.0575817216218791,-0.340143255202126,-0.11442290644436,7.95586901557144e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20609.Liking for bananas,35433,0.0325992768656531,0.0577511739312771,-0.0805930240396501,0.145791577770956,0.572439702283815
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35433,-0.19468996521914,0.057633386683846,-0.307651403119478,-0.0817285273188017,0.000732357320054429
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20611.Liking for beef steak,35433,-0.222922732947015,0.0567976283392296,-0.334246084491905,-0.111599381402125,8.72830275059026e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20612.Liking for beetroot,35433,-0.142262028725153,0.0577759902874962,-0.255502969688645,-0.02902108776166,0.0138192511802684
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20613.Liking for bell pepper,35433,0.0352916351164413,0.0577081440608431,-0.0778163272428112,0.148399597475694,0.540845031058804
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20614.Liking for bicycling,35433,-0.318375874841448,0.0566830862881402,-0.429474723966202,-0.207277025716693,1.99051260670848e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20615.Liking for biscuits,35433,0.174627788225031,0.0571650030486171,0.0625843822497419,0.286671194200321,0.0022572150395827
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20616.Liking for bitter foods,35433,-0.0713566725862121,0.0563754759503922,-0.181852605448981,0.0391392602765567,0.205631824367459
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20617.Liking for bitter or ale,35433,-0.180461304250621,0.0581346020084245,-0.294405124187133,-0.0665174843141093,0.00191256352452244
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20618.Liking for black olives,35433,-0.167578238754809,0.0574805057371664,-0.280240029999655,-0.0549164475099629,0.00355923323254473
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20619.Liking for black pepper,35433,-0.0135917352923681,0.0574409624757805,-0.126176021744898,0.0989925511601617,0.812955054518842
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20620.Liking for blue cheese,35433,-0.0882176724513468,0.0567260896166003,-0.199400808099883,0.0229654631971899,0.119937319372394
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20621.Liking for bolognese sauce,35433,-0.0546984534357388,0.0575868265375228,-0.167568633449284,0.058171726577806,0.342211800550075
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20622.Liking for broad beans,35433,-0.0685490735690785,0.0567072673809815,-0.179695317635802,0.0425971704976452,0.226755403137932
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20623.Liking for broccoli,35433,-0.0990425172281159,0.0587304545027982,-0.2141542080536,0.0160691735973685,0.0917474642874393
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20624.Liking for brown rice,35433,-0.171136924567794,0.0574347048487854,-0.283708946071413,-0.0585649030641743,0.00289151255855831
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20625.Liking for brussel sprouts,35433,-0.0727094661661916,0.0575745019934002,-0.185555490073256,0.0401365577408728,0.206659151144004
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20626.Liking for burgers (meat),35433,-0.164735635854797,0.0567780413894428,-0.276020596978105,-0.0534506747314892,0.00372203732465736
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20627.Liking for burn of spicy foods,35433,-0.0631152131938399,0.0567021373196955,-0.174251402340443,0.0480209759527633,0.265688134822623
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20628.Liking for butter on bread,35433,0.0680582363629001,0.0572745679290772,-0.0441999167780912,0.180316389503891,0.234747429785129
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20629.Liking for butternut squash,35433,-0.25334162767045,0.0569198752797887,-0.364904583218835,-0.141778672122064,8.6332911342839e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20630.Liking for cabbage,35433,-0.0657153695359029,0.0575584589543134,-0.178529949086357,0.0470992100145513,0.253596046192326
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20631.Liking for cake,35433,0.0153015781919662,0.0570508920610601,-0.0965181702477116,0.127121326631644,0.788543022806525
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20632.Liking for cake icing,35433,0.0707487867967586,0.0566488152679976,-0.0402828911285168,0.181780464722034,0.21172640681163
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20633.Liking for capers,35433,-0.245505815516019,0.0567556755307156,-0.356746939556222,-0.134264691475817,1.53350903342918e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20634.Liking for cauliflower,35433,-0.0452561558815652,0.05821019370265,-0.159348135538759,0.0688358237756289,0.436902734802585
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20635.Liking for cereal or granola bar,35433,-0.00487187410199613,0.0565538818381078,-0.115717482504687,0.105973734300695,0.93135208159265
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20636.Liking for cheesecake,35433,0.00581059362247943,0.0568297736581237,-0.105575762747443,0.117196949992402,0.918563516154308
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20637.Liking for cherries,35433,-0.106739998116918,0.0591462920313518,-0.222666730498367,0.00918673426453184,0.0711511255591368
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20638.Liking for chicken,35433,-0.195246522899217,0.0597797894955906,-0.312414910310575,-0.07807813548786,0.00109358839417535
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20639.Liking for chilli pepper,35433,-0.0262425672640607,0.0567911590614317,-0.137553239024467,0.0850681044963455,0.644026224535334
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20640.Liking for chips or french fries,35433,0.117959820796474,0.0572495102923998,0.00575078062337006,0.230168860969577,0.0393777466508766
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20641.Liking for cigarette smoking,35433,-0.0836844868337236,0.088960088838688,-0.258046260957552,0.090677287290105,0.346879816838298
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20642.Liking for cod,35433,-0.171113885526921,0.0583638137265568,-0.285506960430972,-0.0567208106228692,0.00337610788545139
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20643.Liking for coffee with sugar,35433,0.18682795441556,0.0621325964487155,0.0650480653760776,0.308607843455042,0.00264473314925933
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20644.Liking for coffee without sugar,35433,-0.0887013614687368,0.0578766643847337,-0.202139623662815,0.0247369007253413,0.125403561973989
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20645.Liking for coriander,35433,-0.117084415476697,0.0568962799122021,-0.228601124104613,-0.00556770684878066,0.0396262131556302
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20646.Liking for corn flakes,35433,0.194729652481728,0.0566754860078796,0.0836456999062841,0.305813605057172,0.000592728266610436
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20647.Liking for cream,35433,0.02772865615597,0.0569354129698271,-0.0838647532648911,0.139322065576831,0.62625374548398
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20648.Liking for croissant,35433,0.0577209693012942,0.0564414491371715,-0.052904271007562,0.16834620961015,0.306485355936127
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20649.Liking for cucumber,35433,0.00375588164162095,0.0574818292721731,-0.108908503731838,0.11642026701508,0.947904162420247
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20650.Liking for curry,35433,-0.0190257000482796,0.0583101213849853,-0.133313537962851,0.0952621378662915,0.744214872867441
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20651.Liking for dairy products,35433,0.00473437258710593,0.0575638335841056,-0.108090741237741,0.117559486411953,0.934452828453523
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20652.Liking for dark chocolate,35433,-0.0902574052808873,0.0573790776008246,-0.202720397378503,0.0222055868167288,0.11574570646547
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20653.Liking for diet fizzy drinks,35433,0.159046169718148,0.0581768961675257,0.045019453229798,0.273072886206499,0.00626962120008764
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20654.Liking for dried fruit,35433,-0.13957988649984,0.0566943043262554,-0.250700722979301,-0.0284590500203795,0.0138319615841729
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20655.Liking for eggs,35433,-0.169503858557527,0.0585361546956094,-0.284234721760921,-0.0547729953541327,0.00379007676971213
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20656.Liking for exercising alone,35433,-0.191364401464056,0.0564358871393803,-0.301978740257241,-0.0807500626708703,0.000699149116802425
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20657.Liking for exercising with others,35433,-0.22402731591509,0.0567515373538107,-0.335260329128559,-0.112794302701621,7.94355150724522e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20658.Liking for extra virgin olive oil,35433,-0.122586086835663,0.0581706984187641,-0.23660065573644,-0.00857151793488527,0.0351086268273275
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20659.Liking for fatty foods,35433,0.0581440399193645,0.0565293351337491,-0.0526534569427838,0.168941536781513,0.303706107753926
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20660.Liking for fresh tomatoes,35433,0.00531320461463055,0.0605898100005123,-0.113442822986373,0.124069232215635,0.930123482007549
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20661.Liking for fried chicken,35433,-0.117890836127626,0.0565595173300502,-0.228747490094524,-0.00703418216072761,0.0371486166715164
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20662.Liking for fried or battered fish,35433,-0.00494974623161851,0.0571116320500203,-0.116888545049658,0.106989052586421,0.930936978852542
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20663.Liking for fruit,35433,-0.0394336881478553,0.0621421108046187,-0.161232225324908,0.0823648490291974,0.525719679742292
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20664.Liking for garlic,35433,-0.0676780872986087,0.0583287378115772,-0.1820024134093,0.0466462388120827,0.245955851570531
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20665.Liking for gherkins,35433,-0.144921218614794,0.0565050463609066,-0.255671109482171,-0.0341713277474172,0.0103375742754212
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20666.Liking for globe artichoke,35433,-0.0722082991508776,0.0568629481597149,-0.183659677543919,0.0392430792421636,0.204158076932132
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20667.Liking for goat's cheese,35433,-0.20932183599192,0.0570728364736382,-0.321184595480251,-0.0974590765035889,0.000245911039432249
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20668.Liking for going to a cafe,35433,-0.104101327587611,0.057890787811846,-0.217567271698829,0.00936461652360765,0.0721656089438095
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20669.Liking for going to the gym,35433,-0.263374394619577,0.0569908197226842,-0.375076401276038,-0.151672387963116,3.85377853466641e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20670.Liking for going to the pub,35433,-0.163039529528569,0.0569755038419327,-0.274711517058757,-0.0513675419983805,0.00422301494196934
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20671.Liking for grapefruit,35433,-0.0245478472886535,0.0576281294421147,-0.137498980995198,0.0884032864178912,0.670137722917375
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20672.Liking for green olives,35433,-0.169176924495124,0.0572406479199214,-0.28136859441817,-0.0569852545720783,0.00312753721803376
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20673.Liking for haddock,35433,-0.236829078961238,0.0581247599107149,-0.350753608386239,-0.122904549536237,4.64221217941296e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20674.Liking for ham,35433,-0.0784660300865422,0.0571740359792979,-0.190527140605966,0.0335950804328817,0.169963482893552
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20675.Liking for hard cheese,35433,0.0393223815384563,0.0576037404494136,-0.0735809497423944,0.152225712819307,0.494850613615244
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20676.Liking for herring,35433,-0.25006028106296,0.05648852959241,-0.360777799064083,-0.139342763061836,9.6542809424436e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20677.Liking for honey,35433,-0.165293006705241,0.0570710432014267,-0.277152251380038,-0.0534337620304448,0.00378338146300116
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20678.Liking for horseradish or wasabi,35433,-0.191443611912245,0.0568286981322976,-0.302827860251548,-0.0800593635729415,0.000757471380906057
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20679.Liking for ice cream,35433,0.0246813912498418,0.0569776088496904,-0.0869947220955513,0.136357504595235,0.664894245805004
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20680.Liking for jam,35433,0.0990264885725026,0.0570726194555932,-0.0128358455604601,0.210888822705465,0.0827503985845625
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20681.Liking for kiwi fruit,35433,-0.0252994867883305,0.0576467576636417,-0.138287131809068,0.0876881582324073,0.660763252810676
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20682.Liking for lager,35433,-0.130780534238326,0.0576659700383974,-0.243805835513585,-0.0177552329630671,0.0233537931069443
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20683.Liking for lamb,35433,-0.26352002265648,0.0577118004971107,-0.376635151630817,-0.150404893682143,5.0192192240585e-06
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20684.Liking for lemons,35433,-0.0341358807979719,0.0575421576496513,-0.146918509791288,0.0786467481953446,0.553037134855424
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20685.Liking for lentils or beans,35433,-0.0518873862509579,0.0570982896795025,-0.163800034022783,0.0600252615208671,0.363507372249875
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20686.Liking for liver,35433,-0.217547088428997,0.056531350970122,-0.328348536330436,-0.106745640527558,0.000119601625584439
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20687.Liking for mackerel,35433,-0.307387463513728,0.0569474926218248,-0.419004549052504,-0.195770377974951,6.88207237523264e-08
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20688.Liking for marzipan,35433,0.0255927610129045,0.056515792442796,-0.0851781921749756,0.136363714200785,0.650670548034916
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20689.Liking for mayonnaise,35433,-0.108290533404739,0.0573642156607996,-0.220724396099906,0.00414332929042813,0.0590816433291561
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20690.Liking for melon,35433,-0.0380908842889074,0.058309442594398,-0.152377391773927,0.0761956231961127,0.513605445182966
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20691.Liking for milk chocolate,35433,-0.0563950270854521,0.0575453489819049,-0.169183911089986,0.0563938569190814,0.327101601588121
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20692.Liking for mushrooms,35433,-0.0874270551080188,0.0591121084356148,-0.203286787641824,0.0284326774257863,0.139166437425924
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20694.Liking for orange juice,35433,0.18853586465563,0.0574648680385108,0.0759047233001492,0.301167006011112,0.00103786785967104
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20695.Liking for oranges,35433,-0.0230470864358198,0.0571528695735559,-0.135066710799989,0.0889725379283497,0.686769307424135
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20696.Liking for pasta,35433,-0.0412796820711573,0.0573615463409403,-0.1537083128994,0.0711489487570856,0.47176101792827
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20697.Liking for pears,35433,0.0922802477526837,0.0573297122175755,-0.0200859881937643,0.204646483699132,0.107503576186459
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20698.Liking for pizza,35433,0.0328501393116478,0.0571555002671966,-0.0791746412120575,0.144874919835353,0.565471383651063
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20699.Liking for plain yogurt,35433,-0.238957150965531,0.0572582376440624,-0.351183296747893,-0.126731005183169,3.02384265148161e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20700.Liking for plums,35433,-0.0224005087874211,0.0575407367319178,-0.13518035278198,0.0903793352071378,0.697062690467158
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20701.Liking for pollock,35433,-0.148809832012854,0.0565984003988048,-0.259742696794512,-0.0378769672311971,0.00856933780183038
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20702.Liking for pork chop,35433,-0.233154798207309,0.0567746755690187,-0.344433162322586,-0.121876434092033,4.04167750944714e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20703.Liking for porridge,35433,-0.0774568609651621,0.0575698277111783,-0.190293723279072,0.0353800013487474,0.178508937990563
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20704.Liking for potato crisps,35433,0.0114153108985586,0.0568723219923668,-0.10005444020648,0.122885062003598,0.840922446678077
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20705.Liking for potatoes,35433,0.148436502605547,0.0582269283376875,0.0343117230636793,0.262561282147414,0.0108074828970066
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20706.Liking for prawns,35433,-0.19966439408261,0.0581878437090987,-0.313712567752444,-0.0856162204127766,0.000602627026574238
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20707.Liking for raw carrots,35433,-0.0853650723867808,0.057362115595604,-0.197794818954165,0.0270646741806031,0.13673106910829
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20708.Liking for red meat,35433,-0.241643188854982,0.0565962922138043,-0.352571921594038,-0.130714456115926,1.97392034104145e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20709.Liking for red wine,35433,-0.243481490589556,0.0575093936230914,-0.356199902090815,-0.130763079088296,2.31582958959987e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35433,0.114174903206451,0.0591067041092213,-0.00167423684762293,0.230024043260525,0.0534241180831243
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20711.Liking for roast chicken,35433,-0.199835349512206,0.0600396334318198,-0.317513031038573,-0.0821576679858389,0.000876220994659747
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20712.Liking for salad dressing,35433,-0.0297673228768382,0.0574696843450437,-0.142407904193124,0.0828732584394475,0.604492139075519
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20713.Liking for salad leaves,35433,-0.138528534265159,0.0583110179143193,-0.252818129377224,-0.0242389391530927,0.0175326706514272
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20714.Liking for salami,35433,-0.136758845045641,0.0565690978731186,-0.247634276876953,-0.0258834132143281,0.0156405798826795
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20715.Liking for salmon,35433,-0.251192711232525,0.0592427068621374,-0.367308416682314,-0.135077005782735,2.25195476132659e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20716.Liking for salty foods,35433,0.0342105206099094,0.0564013348800893,-0.0763360957550657,0.144757136974884,0.544158073584482
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20717.Liking for salty pretzels,35433,-0.0650458562872396,0.0565285436187617,-0.175841801780013,0.0457500892055334,0.249890672731424
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20718.Liking for sardines,35433,-0.248983416306089,0.0566670317725785,-0.360050798580343,-0.137916034031835,1.12380093567883e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20719.Liking for sausages (meat),35433,-0.142064812673822,0.0571831768277132,-0.25414383925614,-0.0299857860915045,0.0129917212513614
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20720.Liking for savoury biscuits,35433,-0.0183193530293806,0.0570539154668434,-0.130145027344394,0.0935063212856325,0.748149168760266
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35433,-0.23055549982639,0.0567180935786135,-0.341722963240472,-0.119388036412307,4.8363337928368e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20722.Liking for skimmed milk,35433,-0.154305589662419,0.0568953771961686,-0.26582052896691,-0.0427906503579287,0.00669585556943558
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20723.Liking for smoked fish,35433,-0.212197266871089,0.0568041105506002,-0.323533323550265,-0.100861210191912,0.000188170655912007
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20724.Liking for soft cheese,35433,-0.103020583123567,0.0568399404935367,-0.214426866490899,0.00838570024376471,0.0699398090392914
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20725.Liking for soy sauce,35433,-0.0146465977082027,0.0572798079628347,-0.126915021315359,0.0976218258989534,0.798185009876798
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20726.Liking for soya milk,35433,-0.0448645664838702,0.0562002589330947,-0.155017073992736,0.0652879410249954,0.424713846050712
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20727.Liking for spicy foods,35433,-0.0545662013046741,0.0573705901611079,-0.167012558020446,0.0578801554110974,0.341564353195821
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20728.Liking for spinach,35433,-0.193177095158832,0.0576457389437642,-0.30616274348861,-0.080191446829054,0.0008074670026036
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20729.Liking for spirits,35433,-0.0505169006289172,0.0566894875093376,-0.161628296147219,0.0605944948893845,0.372885564564308
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20730.Liking for strawberries,35433,0.0151760500583619,0.0617462827925697,-0.105846664215075,0.136198764331799,0.805856291539102
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35433,0.1127647996577,0.0579636143301306,-0.000843884429356317,0.226373483744756,0.0517461079774908
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20732.Liking for sweet foods,35433,0.0532749606522172,0.0567724568563027,-0.0579990547861362,0.164548976090571,0.348061315523483
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20733.Liking for taking the stairs,35433,-0.20419192549761,0.0586149976966021,-0.31907732098295,-0.0893065300122695,0.000496526021518606
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20734.Liking for tea with sugar,35433,0.14246188030278,0.0686479527639253,0.0079118928854861,0.277011867720073,0.037985133949748
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20735.Liking for tea without sugar,35433,-0.187542932268531,0.0598386364367217,-0.304826659684505,-0.0702592048525561,0.00172787021536129
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20736.Liking for tomato ketchup,35433,0.0445206080312101,0.0566075703679321,-0.0664302298899369,0.155471445952357,0.431603626169298
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20737.Liking for tinned tuna,35433,-0.112341013633228,0.0573395234307244,-0.224726479557448,4.44522909917727e-05,0.0501104627931869
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20738.Liking for turnip (white),35433,-0.0743398341190768,0.0568134513526269,-0.185694198770226,0.0370145305320719,0.190733162323823
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20739.Liking for vegetables,35433,-0.0388391067977885,0.0626131361120131,-0.161560853577334,0.0838826399817572,0.535070642225473
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20740.Liking for vinegar,35433,-0.0333469815607929,0.0569661574736877,-0.145000650209221,0.078306687087635,0.558302095035168
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20741.Liking for watching television,35433,0.0111992223257735,0.0572421701863421,-0.100995431239457,0.123393875891004,0.844890407643845
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20742.Liking for whisky,35433,0.00127026653504696,0.0587069821354478,-0.113795418450431,0.116335951520525,0.982737571852109
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20743.Liking for white bread,35433,0.13333845400505,0.0567351090546175,0.0221376402579999,0.2445392677521,0.0187803926324297
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20744.Liking for white rice,35433,-0.00708720049917001,0.0570359050896396,-0.118877574474864,0.104703173476524,0.901112702209356
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20745.Liking for white wine,35433,-0.129846206011623,0.0565483317881575,-0.240680936316412,-0.0190114757068342,0.0216823204358126
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35433,-0.155735730772291,0.0571545097502544,-0.267758569882789,-0.0437128916617919,0.0064433353064663
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20747.Liking for whole milk,35433,0.0486887699889504,0.0565013453390697,-0.0620538668756262,0.159431406853527,0.388855289543515
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20748.Liking for wholemeal bread,35433,-0.11433014258081,0.0588979697697851,-0.229770163329589,0.0011098781679683,0.0522636320499269
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X20749.Liking for working up a sweat,35433,-0.303691373431468,0.0566170705542847,-0.414660831717866,-0.19272191514507,8.29890070789004e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X21001.Body mass index (BMI),52106,-0.0581133342046664,0.00745993723560674,-0.0727348111864556,-0.0434918572228772,6.92687703762033e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X21002.Weight,52127,-0.0124573690865046,0.00434974416484406,-0.020982867649599,-0.0039318705234103,0.00418726499160534
PLA2G15,Phospholipase A2 group XV,Physical measures,X21021.Pulse wave Arterial Stiffness index,33052,0.0204775604542195,0.00346472565646075,0.0136866981675564,0.0272684227408825,3.53645601669866e-09
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34795,0.15543184928722,0.0603163188510534,0.0372118643391556,0.273651834235285,0.00998076484563385
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34795,0.0526707914750204,0.0629259428228199,-0.0706640564577066,0.176005639407748,0.402594988875757
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34795,-0.0771503950536585,0.0620389406921889,-0.198746718810349,0.0444459287030319,0.213680792954548
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21040.Satisfaction with bowel habits,34764,-0.00781199669997171,0.0574260991425954,-0.120367151019459,0.104743157619515,0.891795611926611
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34762,0.0945036354167103,0.0611783732574891,-0.0254059761679684,0.214413247001389,0.122442347573247
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21042.Greatest number of times bowels opened per day,34753,0.0880420261860068,0.0624883362991153,-0.0344351129602591,0.210519165332273,0.15888283116237
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21043.Least number of times bowels opened per week,34696,-0.00841082489998799,0.0616925268352459,-0.12932817749707,0.112506527697094,0.891559318967357
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21044.Average number of times bowels opened per day,34726,0.245167452206111,0.0694638653483831,0.10901827612328,0.381316628288942,0.000418188275095445
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34800,-0.103847605048762,0.0629804328468558,-0.227289253428599,0.0195940433310758,0.0991995407672324
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34795,-0.12647148501303,0.0629382455925918,-0.249830446374509,-0.00311252365154971,0.044513575485567
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30249,0.212393752147607,0.0951612030304245,0.0258777942079746,0.398909710087238,0.0256537104192096
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34797,-0.000389528159470243,0.0669149929027608,-0.131542914248882,0.130763857929941,0.995355455770704
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34795,-0.0812610622135945,0.0937659866816531,-0.265042396109635,0.102520271682446,0.386160016273503
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34798,-0.169585116155212,0.0749547709286007,-0.316496467175269,-0.0226737651351543,0.0236861042176397
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34796,-0.0859331071283615,0.185120088499122,-0.448768480586641,0.276902266329918,0.642512301155995
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34798,-0.0697239052640467,0.0710482717455194,-0.208978517885265,0.0695307073571713,0.326437136857038
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34798,-0.252501811216864,0.0736916841480159,-0.396937512146975,-0.108066110286753,0.00061374701617426
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34549,0.107188971506066,0.0656789679882281,-0.0215418057508611,0.235919748762993,0.102706075779972
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34798,-0.112711012537396,0.0657059026411117,-0.241494581713975,0.0160725566391827,0.0863027290300161
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34799,-0.303656633139152,0.0907530195676027,-0.481532551491653,-0.125780714786651,0.000822721544331177
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34797,-0.303752718025588,0.0627694049820252,-0.426780751790358,-0.180724684260819,1.32154474793867e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34795,-0.118011845181477,0.0629448765675558,-0.241383803253887,0.00536011289093201,0.0608407771739428
PLA2G15,Phospholipase A2 group XV,Working and living environment,X21100.Water hardness (USGS classification),51862,-0.00338768262601992,0.0381665238911456,-0.0781940694526653,0.0714187042006255,0.929272824956564
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2139.Age first had sexual intercourse,49159,-0.00337732306002487,0.0020047217340815,-0.00730657765882462,0.000551931538774874,0.0920618480739347
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2149.Lifetime number of sexual partners,47130,-0.0287267418039043,0.0428669847090732,-0.112746031833688,0.0552925482258791,0.502777270003703
PLA2G15,Phospholipase A2 group XV,Physical activities,X22032.IPAQ activity group,47097,-0.345309715183097,0.0418238109882973,-0.42728438472016,-0.263335045646035,1.58182031765905e-16
PLA2G15,Phospholipase A2 group XV,Physical activities,X22033.Summed days activity,47683,-0.0139869760190689,0.00192298652173201,-0.0177560296016636,-0.0102179224364741,3.60927795678982e-13
PLA2G15,Phospholipase A2 group XV,Physical activities,X22034.Summed minutes activity,47097,-0.0136568743350355,0.00196673114448969,-0.0175116673782353,-0.00980208129183572,3.91343417723681e-12
PLA2G15,Phospholipase A2 group XV,Physical activities,X22037.MET minutes per week for walking,46328,-0.00423329735610422,0.00192922808061075,-0.00801458439410129,-0.000452010318107154,0.0282243413257729
PLA2G15,Phospholipase A2 group XV,Physical activities,X22038.MET minutes per week for moderate activity,47097,-0.00983450399597115,0.00201608288993049,-0.0137860264602349,-0.00588298153170739,1.07861612187182e-06
PLA2G15,Phospholipase A2 group XV,Physical activities,X22039.MET minutes per week for vigorous activity,47097,-0.466908152184673,0.0420012833006129,-0.549230667453874,-0.384585636915472,1.23130135965529e-28
PLA2G15,Phospholipase A2 group XV,Physical activities,X22040.Summed MET minutes per week for all activity,46328,-0.0138935655325313,0.00198662230711171,-0.0177873452544702,-0.00999978581059231,2.75509351951458e-12
PLA2G15,Phospholipase A2 group XV,Eye measures,X2217.Age started wearing glasses or contact lenses,46472,-0.00360153906057865,0.00232567836355584,-0.0081598686531481,0.000956790531990802,0.121492568196076
PLA2G15,Phospholipase A2 group XV,Working and living environment,X22501.Year ended full time education,31418,0.00390150930170432,0.00950920772316578,-0.0147365378357006,0.0225395564391093,0.681606671831471
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X22506.Tobacco smoking,31368,0.0592702664083759,0.147686887131455,-0.230196032369275,0.348736565186027,0.688193149481978
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50176,-0.184941471990569,0.0838369621787661,-0.349261917860951,-0.0206210261201877,0.0273950029251136
PLA2G15,Phospholipase A2 group XV,Physical measures,X23098.Weight,51745,-0.0122867711729711,0.00437147707997077,-0.0208548662497138,-0.00371867609622837,0.0049473218115749
PLA2G15,Phospholipase A2 group XV,Physical measures,X23099.Body fat percentage,51723,0.0276478893562393,0.00423185254207823,0.019353458373766,0.0359423203387127,6.54524477225886e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23100.Whole body fat mass,51687,0.022231365250621,0.00402250299874335,0.014347259373084,0.030115471128158,3.29140799801621e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23101.Whole body fat-free mass,51740,-0.0179129558217714,0.00373573544701173,-0.0252349972979144,-0.0105909143456284,1.63490890702448e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23102.Whole body water mass,51745,-0.0178145468048653,0.00373491139856668,-0.025134973146056,-0.0104941204636746,1.85398041096914e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23104.Body mass index (BMI),51745,-0.0579277596104912,0.00750611089730354,-0.0726397369692061,-0.0432157822517763,1.22674615142009e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X23105.Basal metabolic rate,51743,-0.0187429861496091,0.00400399389157396,-0.0265908141770941,-0.0108951581221242,2.86719129963645e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X23106.Impedance of whole body,51742,0.0270240444928483,0.00306914425545296,0.0210085217521605,0.0330395672335361,1.38183250042689e-18
PLA2G15,Phospholipase A2 group XV,Physical measures,X23107.Impedance of leg (right),51742,0.0231204556721395,0.00252972325803154,0.0181621980863977,0.0280787132578813,6.68712408643656e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X23108.Impedance of leg (left),51741,0.0228637019352625,0.00251091591856902,0.0179423067348673,0.0277850971356578,9.12669600751535e-20
PLA2G15,Phospholipase A2 group XV,Physical measures,X23109.Impedance of arm (right),51735,0.0200753588792899,0.00307951621979388,0.0140395070884939,0.0261112106700859,7.19876439807103e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23110.Impedance of arm (left),51740,0.0200852708285704,0.00307647179316833,0.0140553861139604,0.0261151555431803,6.74957834440716e-11
PLA2G15,Phospholipase A2 group XV,Physical measures,X23111.Leg fat percentage (right),51741,0.041498447811774,0.00524374864842897,0.0312207004608532,0.0517761951626948,2.58674334240683e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X23112.Leg fat mass (right),51740,0.0325207241099042,0.00543392161341512,0.0218702377476105,0.0431712104721978,2.19351666730882e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,X23113.Leg fat-free mass (right),51740,-0.0177196900594962,0.00401751507839884,-0.025594019613158,-0.00984536050583451,1.03465731082458e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23114.Leg predicted mass (right),51739,-0.017070604166473,0.00403327782428897,-0.0249758287020794,-0.00916537963086665,2.31909090034065e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23115.Leg fat percentage (left),51738,0.0429496521603438,0.00542292556648363,0.0323207180500359,0.0535785862706517,2.46272436394684e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X23116.Leg fat mass (left),51738,0.0313210341523716,0.0056515295040053,0.0202440363245212,0.042398031980222,3.01660320269125e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23117.Leg fat-free mass (left),51736,-0.0152936208864628,0.00416777023200185,-0.0234624505411864,-0.00712479123173916,0.000243480880742517
PLA2G15,Phospholipase A2 group XV,Physical measures,X23118.Leg predicted mass (left),51735,-0.0153605739366978,0.00418435658354818,-0.0235619128404522,-0.00715923503294336,0.000242099249921731
PLA2G15,Phospholipase A2 group XV,Physical measures,X23119.Arm fat percentage (right),51735,0.0112082252925079,0.00466646344328747,0.0020619569436645,0.0203544936413514,0.0163181327682255
PLA2G15,Phospholipase A2 group XV,Physical measures,X23120.Arm fat mass (right),51732,-0.00440412044359462,0.00456174269208756,-0.0133451361200862,0.004536895232897,0.334329385377471
PLA2G15,Phospholipase A2 group XV,Physical measures,X23121.Arm fat-free mass (right),51732,-0.0153227549470943,0.00373972876755231,-0.0226526233314968,-0.00799288656269175,4.19195563719065e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X23122.Arm predicted mass (right),51731,-0.0145252285252453,0.0037409720472882,-0.0218575337379302,-0.00719292331256045,0.000103523316017821
PLA2G15,Phospholipase A2 group XV,Physical measures,X23123.Arm fat percentage (left),51727,0.0129158468857845,0.00477107059269259,0.00356454852410707,0.022267145247462,0.00679116669206782
PLA2G15,Phospholipase A2 group XV,Physical measures,X23124.Arm fat mass (left),51726,-0.00523882587261085,0.00454249515881274,-0.0141421163838838,0.00366446463866213,0.248800214768818
PLA2G15,Phospholipase A2 group XV,Physical measures,X23125.Arm fat-free mass (left),51722,-0.0190914637352374,0.00379759209597737,-0.026534744243353,-0.0116481832271217,5.00632186153656e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23126.Arm predicted mass (left),51721,-0.0194784717929859,0.00381663824262476,-0.0269590827485304,-0.0119978608374413,3.35497489570033e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23127.Trunk fat percentage,51718,0.0168499030862709,0.00303363099463651,0.0109039863367833,0.0227958198357584,2.81159637543669e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23128.Trunk fat mass,51714,0.018085086765634,0.00330821397686674,0.0116009873709752,0.0245691861602928,4.62365203490951e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X23129.Trunk fat-free mass,51708,-0.0174758169481939,0.0034011185746941,-0.0241420093545944,-0.0108096245417935,2.79170274858419e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X23130.Trunk predicted mass,51706,-0.0170933244594644,0.00339618929622854,-0.0237498554800723,-0.0104367934388564,4.85642195063431e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23400.Total Cholesterol,39913,-0.00768909038746464,0.00257184622870855,-0.0127299089957334,-0.00264827177919587,0.00279659888324306
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39913,-0.00433202991366,0.00249725584208121,-0.00922665136413918,0.000562591536819181,0.0828102973033615
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39913,0.00300953239898566,0.00250854572990828,-0.00190721723163457,0.0079262820296059,0.230268919293694
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23403.VLDL Cholesterol,39913,0.0121291170494026,0.0024712971250509,0.00728537468430288,0.0169728594145024,9.29145546526055e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23404.Clinical LDL Cholesterol,39913,-0.0141881381771174,0.00249222128179984,-0.0190728918894451,-0.00930338446478968,1.270319449033e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23405.LDL Cholesterol,39913,-0.0106679932744349,0.00247290046781575,-0.0155148781913538,-0.00582110835751604,1.61314361999584e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23406.HDL Cholesterol,39913,-0.0184321187680308,0.00282109280013737,-0.0239614606563001,-0.0129027768797616,6.61036718242386e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23407.Total Triglycerides,39913,0.0354747768472041,0.00251926553731357,0.0305370163940695,0.0404125373003387,9.12729734263864e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23408.Triglycerides in VLDL,39913,0.0297647979737762,0.00256519325779607,0.0247370191884959,0.0347925767590565,5.26961845935869e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23409.Triglycerides in LDL,39913,0.0433460127766081,0.00239616764278332,0.0386495241967528,0.0480425013564634,2.010368561106e-72
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23410.Triglycerides in HDL,39913,0.0498418985100116,0.00235924085149979,0.045217786441072,0.0544660105789512,9.73080856776385e-98
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39913,0.0121520339909371,0.00254573694822808,0.0071623895724101,0.0171416784094642,1.82662172896145e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23412.Phospholipids in VLDL,39913,0.0222459789418551,0.00249304012177466,0.0173596203031767,0.0271323375805334,5.00933105626881e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23413.Phospholipids in LDL,39913,-0.00908454439345857,0.00247522831776217,-0.0139359918962724,-0.00423309689064472,0.000243160645238107
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23414.Phospholipids in HDL,39913,0.00765256443453668,0.00265328319610967,0.00245212937016172,0.0128529994989116,0.00392947654263995
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23415.Total Esterified Cholesterol,39913,-0.00933606414138814,0.0025808446504511,-0.0143945196562723,-0.00427760862650398,0.000298438080230327
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39913,0.00786847688209625,0.00247228685169502,0.003022794652774,0.0127141591114185,0.00146201206624452
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39913,-0.00756604838663206,0.00246451954430316,-0.0123965066934663,-0.00273559007979786,0.0021442390890038
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39913,-0.0231368702447577,0.00281365611037315,-0.0286516362210891,-0.0176221042684263,2.1341424758815e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23419.Total Free Cholesterol,39913,-0.00357014639222232,0.00254711565704156,-0.00856249308002378,0.00142220029557913,0.161041264730075
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23420.Free Cholesterol in VLDL,39913,0.0172211866452635,0.00248335175398565,0.0123538172074516,0.0220885560830754,4.22743863826116e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23421.Free Cholesterol in LDL,39913,-0.0189823618302917,0.00249919866626911,-0.0238807912161792,-0.0140839324444043,3.23753550823263e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23422.Free Cholesterol in HDL,39913,-0.00121909337075077,0.00280107222679046,-0.00670919493526007,0.00427100819375853,0.663405821195449
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39913,0.0119913190048216,0.00248094766090664,0.00712866158944458,0.0168539764201986,1.35487772025658e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23424.Total Lipids in VLDL,39913,0.0248769075669309,0.00251464186301175,0.0199482095154279,0.029805605618434,5.20435750161571e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23425.Total Lipids in LDL,39913,-0.00673716911096775,0.00247097422694916,-0.0115802785957881,-0.0018940596261474,0.00640748819364336
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23426.Total Lipids in HDL,39913,0.000928660669114435,0.00271186026299818,-0.00438658544636199,0.00624390678459086,0.732021154846166
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39913,-0.00347272586550124,0.00255624536227075,-0.00848296677555192,0.00153751504454943,0.174315917917843
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23428.Concentration of VLDL Particles,39913,0.0192882076188266,0.00246251859322593,0.0144616711761038,0.0241147440615495,5.0715123217617e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23429.Concentration of LDL Particles,39913,-0.00719210087010126,0.00247692620171938,-0.0120468762254712,-0.00233732551473128,0.00369355109804834
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23430.Concentration of HDL Particles,39913,-0.00356848702100559,0.00255658614973524,-0.00857939587448666,0.00144242183247547,0.162793554488064
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39913,0.0183151916266347,0.00270317441218154,0.0130169697787589,0.0236134134745105,1.28341161222094e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23432.Average Diameter for LDL Particles,39913,-0.0353841454585317,0.00245482645742797,-0.0401956053150905,-0.0305726856019729,8.26762311508445e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23433.Average Diameter for HDL Particles,39913,-0.00846581939833159,0.00286924415303605,-0.0140895379382822,-0.00284210085838093,0.00317677194687632
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23434.Phosphoglycerides,39901,0.0163726526541408,0.00251554096234114,0.0114421923679521,0.0213031129403294,7.81033411757913e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39901,0.0367467491698209,0.00269862551727558,0.0314574431559608,0.042036055183681,5.44366470945187e-42
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23436.Total Cholines,39901,0.011541786448749,0.00255999596596235,0.0065241943554628,0.0165593785420352,6.5744466072134e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23437.Phosphatidylcholines,39901,0.0145080303564922,0.00255230869899742,0.00950550530645727,0.0195105554065272,1.33651750844308e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23438.Sphingomyelins,39900,-0.00491950797349877,0.00264268559274834,-0.0100991717352855,0.000260155788287989,0.0626839375318322
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23439.Apolipoprotein B,39913,-0.00316548984603384,0.00248584161695371,-0.00803773941526311,0.00170675972319543,0.202891846389704
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23440.Apolipoprotein A1,39913,0.00339173430868348,0.00263563282233786,-0.00177410602309873,0.00855757464046569,0.198155844794014
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39913,-0.00453469466009177,0.00248747320889951,-0.00941014214953481,0.00034075282935127,0.0683200933259781
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23442.Total Fatty Acids,39901,0.0234519930016637,0.00241234531787146,0.0187237961786356,0.0281801898246918,2.80862196679359e-22
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23443.Degree of Unsaturation,39901,-0.0803326470734791,0.00260524916233532,-0.0854389354316563,-0.0752263587153019,7.08398293940621e-203
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23444.Omega-3 Fatty Acids,39901,-0.0274466673686745,0.0024483413365153,-0.0322454163882445,-0.0226479183491045,4.65411005685069e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23445.Omega-6 Fatty Acids,39901,-0.00104920989836783,0.00245521098116534,-0.00586142342145189,0.00376300362471624,0.669137427093647
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39901,-0.00732995968052193,0.00245661398880167,-0.0121449230985732,-0.00251499626247066,0.00285153703093438
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39901,0.0344424215572614,0.0024467395103208,0.0296468121170326,0.0392380309974902,9.7285146662843e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23448.Saturated Fatty Acids,39901,0.0361343694140334,0.0024146023016569,0.0314017489027859,0.040866989925281,2.71838738429018e-50
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23449.Linoleic Acid,39901,0.00249942644356789,0.00247270557501328,-0.00234707648345815,0.00734592937059392,0.312124380017572
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23450.Docosahexaenoic Acid,39901,-0.0411011531513732,0.00254749856573971,-0.0460942503402231,-0.0361080559625234,4.22234155346485e-58
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39901,-0.048760359217943,0.00245611945643953,-0.0535743533525645,-0.0439463650833215,1.14669174687151e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39901,-0.0498215937913388,0.00250087480943451,-0.0547233084178304,-0.0449198791648471,2.99105840179924e-87
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39901,-0.072281245255922,0.00257168594093632,-0.0773217497001572,-0.0672407408116868,1.02698275538601e-169
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39901,0.0505587944281188,0.00266368967438905,0.0453379626663163,0.0557796261899213,1.82611881431604e-79
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39901,0.0622707918347635,0.00237439114429754,0.0576169851919403,0.0669245984775867,1.77999404162136e-148
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39901,-0.0369728062379936,0.0025733211384767,-0.0420165156694079,-0.0319290968065793,1.60362879948928e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39901,-0.0573796829319466,0.0025587260905534,-0.0623947860694313,-0.052364579794462,1.08070155553048e-109
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39901,-0.0634016467880841,0.00264344638162426,-0.0685828016960677,-0.0582204918801006,6.33335834988566e-125
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39899,0.0310864036946766,0.0024523246309572,0.0262798474180005,0.0358929599713528,1.19947447358871e-36
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23460.Alanine,39909,0.0200650729293623,0.00239271982387886,0.0153753420745597,0.0247548037841648,5.44832834739468e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23461.Glutamine,39872,-0.0124466148979351,0.00236966093433576,-0.0170911503292332,-0.00780207946663697,1.51979251576616e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23462.Glycine,39894,-0.00332726084116748,0.00249251109977777,-0.00821258259673191,0.00155806091439694,0.181927010098208
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23463.Histidine,39895,-0.012224197044076,0.00236464400212969,-0.0168588992882502,-0.0075894947999018,2.37449993467294e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39901,-0.00831417922449528,0.00251937996332249,-0.0132521639526074,-0.00337619449638321,0.000968647835149975
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23465.Isoleucine,39911,-0.00940505461839092,0.00245723835479277,-0.0142212417937847,-0.0045888674429971,0.000129947936125859
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23466.Leucine,39912,-0.0102937107905224,0.00253511979518139,-0.0152625455890779,-0.00532487599196684,4.92119793927547e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23467.Valine,39901,-0.00590149335209678,0.00250939126242137,-0.0108199002264427,-0.000983086477750897,0.0186967032878185
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23468.Phenylalanine,39909,0.000711307275989848,0.00239193825635097,-0.00397689170645805,0.00539950625843775,0.766182596965564
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23469.Tyrosine,39896,0.0162703146640259,0.00243960869677435,0.0114886816183482,0.0210519477097036,2.65550215239385e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23470.Glucose,39886,0.0129161146056317,0.00244206474584519,0.0081296677037751,0.0177025615074882,1.24593214988204e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23471.Lactate,39885,0.0316316351330708,0.00238823668655495,0.0269506912274231,0.0363125790387185,7.83436782497692e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23472.Pyruvate,39868,0.0133541055179832,0.00236824612653892,0.00871234310996688,0.0179958679259994,1.74114558133263e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23473.Citrate,39912,0.0100722685511954,0.00242307427142761,0.00532304297919725,0.0148214941231935,3.24390895636712e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23474.3-Hydroxybutyrate,39656,0.00535376969851759,0.00233347201011323,0.000780164558695662,0.00992737483833952,0.0217842413943017
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23475.Acetate,39899,-0.0188973971175619,0.00239431864937993,-0.0235902616703466,-0.0142045325647773,3.14966896460109e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23476.Acetoacetate,39913,-0.00652582191780318,0.00235163465069432,-0.011135025833164,-0.00191661800244231,0.00552629639496385
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23477.Acetone,39913,-0.017235828918088,0.00236004375773739,-0.0218615146832533,-0.0126101431529227,2.94226457415774e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23478.Creatinine,39493,-0.0140136573374902,0.00296440254886586,-0.0198238863332673,-0.0082034283417131,2.29494652810624e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23479.Albumin,39912,-0.0173806728256216,0.00243076311668987,-0.0221449685343338,-0.0126163771169095,9.03241925284845e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23480.Glycoprotein Acetyls,39913,0.0343639495078433,0.00253516978690039,0.0293950167255186,0.0393328822901681,1.25606269326275e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39913,0.0370038943595628,0.00254393080823961,0.0320177899754132,0.0419899987437125,1.24486586725999e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39913,0.0360187456486674,0.00255572998165853,0.0310095148846167,0.0410279764127181,7.72440021709355e-45
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39913,0.0372150805581957,0.00255755657286619,0.0322022696753779,0.0422278914410134,1.15693597117544e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39913,0.0370859023881176,0.00253802268843324,0.0321113779187884,0.0420604268574467,4.78291670010516e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39913,0.0369942661822376,0.00254904209789901,0.0319981436703556,0.0419903886941197,2.0011004357339e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39913,0.0366190099016548,0.00251724162855196,0.0316852163096929,0.0415528034936166,1.22130122859968e-47
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39913,0.0338273857421211,0.0025536419902322,0.028822247441266,0.0388325240429762,7.62861430887367e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39913,0.0315277073137904,0.00259650441179568,0.0264385586666709,0.03661685596091,8.85719114913595e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39913,0.03050876205631,0.00260022794992777,0.0254123152744515,0.0356052088381684,1.16134316599919e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39913,0.0300217608819538,0.0025834124884104,0.0249582724046694,0.0350852493592382,4.29476363334509e-31
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39913,0.0228262740484744,0.00255047208743877,0.0178273487570944,0.0278251993398544,3.94310575053016e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39913,0.0169166072380737,0.0025307229220972,0.0119563903107632,0.0218768241653843,2.39354243951372e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39913,0.0277259944061527,0.00256504650952073,0.0226985032474921,0.0327534855648133,3.86304093971258e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39913,0.0323784584196951,0.00262207384967014,0.0272391936743417,0.0375177231650486,7.15315261579364e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39913,0.0259180814680687,0.0025733716034907,0.0208742731252269,0.0309618898109104,8.67640616222942e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23496.Total Lipids in Large VLDL,39913,0.0227279141175449,0.00257843156200132,0.0176741882560223,0.0277816399790675,1.32197982322726e-18
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23497.Phospholipids in Large VLDL,39913,0.0276747894661983,0.00258765944628163,0.0226029769514864,0.0327466019809103,1.32160263149371e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23498.Cholesterol in Large VLDL,39913,0.0190404876818051,0.00253523332488553,0.0140714303650294,0.0240095449985807,6.20659871820341e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39913,0.0128842316496343,0.00249662154399158,0.00799085342341079,0.0177776098758578,2.49005427535362e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39913,0.0242483500779857,0.00257856344045556,0.0191943657346928,0.0293023344212785,5.95672106529832e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23501.Triglycerides in Large VLDL,39913,0.0209347716924483,0.00259424029441239,0.0158500607154001,0.0260194826694966,7.54129655559713e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39913,0.00359681060752426,0.00246969837540372,-0.00124379820826702,0.00843741942331554,0.145308133424506
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39913,0.00802483874213574,0.00247834938660109,0.0031672739443976,0.0128824035398739,0.00120624946175949
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39913,0.00379970839036951,0.00246885373161343,-0.00103924492359281,0.00863866170433184,0.123809915817494
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39913,-0.012930375656463,0.00249059213764992,-0.0178119362462569,-0.0080488150666692,2.10939634547393e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39913,-0.0214879757480846,0.00251558248586162,-0.0264185174203734,-0.0165574340757959,1.4367366705317e-17
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39913,-0.0017529451257753,0.002468024684122,-0.00659027350665442,0.00308438325510382,0.477551751678792
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39913,0.0191239136144467,0.0025374301439592,0.0141505505322867,0.0240972766966068,5.07583350431207e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39913,0.0187830786320245,0.00247427048059129,0.0139335084900656,0.0236326487739834,3.33920119786136e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23510.Total Lipids in Small VLDL,39913,0.0178049012061301,0.00246867537603186,0.0129662974691077,0.0226435049431526,5.74566922614792e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23511.Phospholipids in Small VLDL,39913,0.00641032087169927,0.00245615662159466,0.00159625389337373,0.0112243878500248,0.00906530138527159
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23512.Cholesterol in Small VLDL,39913,0.00595084792496406,0.00246100703022538,0.00112727414572232,0.0107744217042058,0.0156148186967458
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39913,0.0103144732024777,0.00246429463977217,0.0054844557085243,0.0151444906964312,2.85968437319309e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39913,-0.00175723511573056,0.00246217127396736,-0.00658309081270659,0.00306862058124548,0.475427232509833
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23515.Triglycerides in Small VLDL,39913,0.0302317907776765,0.00249094788201764,0.0253495329289219,0.0351140486264311,9.49070969814784e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39913,0.0219647304164252,0.00246869362999907,0.017126090901627,0.0268033699312234,6.321673948443e-19
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39913,0.0225652955759784,0.00246138496335318,0.0177409810478062,0.0273896101041506,5.40491778125076e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39913,0.0243176063793493,0.00244551091614269,0.0195244049837096,0.0291108077749889,3.1337472776421e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39913,0.00850675215530271,0.00255900943009658,0.00349109367231342,0.013522410638292,0.000888595043854159
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39913,0.00426686000343898,0.00259336975397191,-0.000816144714345961,0.00934986472122392,0.0999284323224734
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39913,0.01723584402827,0.00248271789380842,0.0123697169564055,0.0221019711001345,4.00461269683467e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39913,0.041619423720272,0.00240836335612211,0.0368990315422726,0.0463398158982713,2.5934308233438e-66
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23523.Concentration of IDL Particles,39913,-0.00171684202558112,0.00254101998027878,-0.00669724118692754,0.0032635571357653,0.499272151880445
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23524.Total Lipids in IDL,39913,-0.00323619418546718,0.00259927983326734,-0.00833078265867117,0.00185839428773681,0.213137084963604
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23525.Phospholipids in IDL,39913,-0.00350249211152886,0.00259842933319648,-0.00859541360459397,0.00159042938153624,0.177701000273983
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23526.Cholesterol in IDL,39913,-0.0100195948913964,0.00261399297975865,-0.0151430211317234,-0.00489616865106945,0.000127041236193453
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39913,-0.00953136547550577,0.00260993676738125,-0.014646841539573,-0.00441588941143851,0.00026108128617771
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23528.Free Cholesterol in IDL,39913,-0.0111656822902946,0.00261470212630025,-0.016290498457843,-0.00604086612274607,1.96292014346623e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23529.Triglycerides in IDL,39913,0.043987532920748,0.00237281864126416,0.0393368083838702,0.0486382574576257,6.30608475450761e-76
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23530.Concentration of Large LDL Particles,39913,-0.0122987637338807,0.0024788142882003,-0.0171572397387533,-0.0074402877290081,7.06481770793264e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23531.Total Lipids in Large LDL,39913,-0.00870138502182171,0.00248955405895557,-0.0135809109773746,-0.00382185906626879,0.000475059140641639
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23532.Phospholipids in Large LDL,39913,-0.0101346266509698,0.00249789918555975,-0.0150305090546669,-0.00523874424727271,4.98866525821244e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23533.Cholesterol in Large LDL,39913,-0.0130666445626442,0.00249233392332562,-0.0179516190523624,-0.00818167007292597,1.60219688512904e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39913,-0.0112650829906495,0.00247871472865661,-0.0161233638588165,-0.00640680212248257,5.54077137478495e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39913,-0.0179669185083136,0.00253250692958258,-0.0229306320902954,-0.0130032049263317,1.3522411381929e-12
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23536.Triglycerides in Large LDL,39913,0.044241193233544,0.00238070551948947,0.0395750104153446,0.0489073760517433,2.77046987180021e-76
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39913,0.00039216779506991,0.00246754043845797,-0.00444421146430771,0.00522854705444753,0.873725515104013
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23538.Total Lipids in Medium LDL,39913,-0.00282397895934407,0.00245435142903489,-0.00763450776025246,0.00198654984156432,0.249913601923432
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23539.Phospholipids in Medium LDL,39913,-0.00598743715172368,0.00244876408639711,-0.010787014761062,-0.00118785954238534,0.0144924589624664
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23540.Cholesterol in Medium LDL,39913,-0.00565711527143773,0.0024552354162903,-0.0104693766873667,-0.000844853855508741,0.0212295687356331
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39913,-0.000871899441054513,0.00245953771969628,-0.00569259337165922,0.0039487944895502,0.722970895703656
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39913,-0.0184502178693171,0.00245033122131564,-0.0232528670630958,-0.0136475686755384,5.35619285495034e-14
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23543.Triglycerides in Medium LDL,39913,0.0413889281016681,0.00241857745980366,0.0366485162804529,0.0461293399228832,4.48876431092186e-65
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23544.Concentration of Small LDL Particles,39913,0.00199088270646059,0.00247679820022242,-0.00286364176597536,0.00684540717889654,0.421516856307692
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23545.Total Lipids in Small LDL,39913,-0.00550411677524406,0.00247016727301862,-0.0103456446303605,-0.000662588920127567,0.0258785481066064
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23546.Phospholipids in Small LDL,39913,-0.010953813388752,0.00247168693602351,-0.0157983197833581,-0.00610930699414597,9.41056015659048e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23547.Cholesterol in Small LDL,39913,-0.00846031308561281,0.00246689564182571,-0.0132954285435912,-0.00362519762763442,0.000606128878233644
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39913,-0.00184639904513938,0.00246935984087026,-0.00668634433324509,0.00299354624296633,0.454637744481194
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39913,-0.0245921313478815,0.0024523413380384,-0.0293987203704367,-0.0197855423253262,1.34703816281853e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23550.Triglycerides in Small LDL,39913,0.0379447523036742,0.00245446632454566,0.0331339983075647,0.0427555062997837,1.58312606526303e-53
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39913,-0.00780037605804125,0.00289196790131289,-0.0134686331446145,-0.00213211897146799,0.00699866272229426
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39913,-0.0130711245388521,0.00289976527910547,-0.0187546644858989,-0.00738758459180541,6.60133115145674e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39913,-0.0106578809024747,0.00286726357716991,-0.0162777175137277,-0.00503804429122168,0.000202214220171693
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39913,-0.0228177366563715,0.00293880476046307,-0.0285777939868791,-0.0170576793258639,8.7033166722475e-15
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39913,-0.0270751389014811,0.00297139711327641,-0.0328990772435029,-0.0212512005594593,9.03056888411836e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39913,-0.00783390524659839,0.0027708726055373,-0.0132648155534515,-0.00240299493974528,0.00470100835682469
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39913,0.0404171991205718,0.00233092745346452,0.0358485813117814,0.0449858169293623,9.59346753032963e-67
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23558.Concentration of Large HDL Particles,39913,-0.0185294401400782,0.0029572280649135,-0.0243256071473087,-0.0127332731328477,3.80338628087748e-10
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23559.Total Lipids in Large HDL,39913,-0.014585832323979,0.00291448384947676,-0.0202982206689534,-0.00887344397900449,5.65698834340792e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23560.Phospholipids in Large HDL,39913,-0.00820607899635509,0.00285496832624339,-0.0138018169157921,-0.00261034107691806,0.00405436310535057
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23561.Cholesterol in Large HDL,39913,-0.027791597889105,0.00297763157458869,-0.0336277557752988,-0.0219554400029111,1.15589114054042e-20
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39913,-0.0317393037246193,0.00298050293825765,-0.0375810894836043,-0.0258975179656343,2.15937550468352e-26
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39913,-0.0140718943792233,0.002944312740395,-0.0198427473503975,-0.00830104140804912,1.77422347390546e-06
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23564.Triglycerides in Large HDL,39913,0.0450579877861403,0.00234685731177333,0.0404581474550646,0.049657828117216,3.05032991302989e-81
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39913,0.00290202978017091,0.0026061146592331,-0.00220595495192596,0.00801001451226779,0.265490474655193
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23566.Total Lipids in Medium HDL,39913,0.0073214464050485,0.00256311236679309,0.00229774616613404,0.012345146643963,0.00428934267718633
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23567.Phospholipids in Medium HDL,39913,0.0129904652202894,0.00251872102713967,0.00805377200709566,0.0179271584334832,2.53158711953754e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23568.Cholesterol in Medium HDL,39913,-0.00764690094097723,0.00264588210654205,-0.0128328298697997,-0.00246097201215481,0.00385618012154774
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39913,-0.0100569681221633,0.00264052130984231,-0.0152323898894542,-0.00488154635487234,0.000140216402150024
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39913,0.0022909110464209,0.00265239394482763,-0.00290778108544126,0.00748960317828307,0.387757663831882
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23571.Triglycerides in Medium HDL,39913,0.049232925515757,0.00236748370046096,0.0445926574628535,0.0538731935686604,8.42767377694769e-95
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23572.Concentration of Small HDL Particles,39913,-0.00242920900383084,0.0023807177141522,-0.00709541572356915,0.00223699771590748,0.307569175650565
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23573.Total Lipids in Small HDL,39913,0.0128283028959177,0.00238825500610696,0.0081473230839481,0.0175092827078874,7.92105190868575e-08
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23574.Phospholipids in Small HDL,39913,0.0176776043881815,0.00238950896554452,0.0129941668157142,0.0223610419606487,1.45074518982643e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23575.Cholesterol in Small HDL,39913,-0.00615595107660705,0.00237781269049697,-0.0108164639499811,-0.001495438203233,0.00963661529078264
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39913,-0.0123166844596719,0.00236901009258071,-0.0169599442411301,-0.00767342467821368,2.02729404418581e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39913,0.0138636815661497,0.00241187295268401,0.00913641057888905,0.0185909525534104,9.18917085101487e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23578.Triglycerides in Small HDL,39913,0.0486466212647604,0.00255343367234899,0.0436418912669563,0.0536513512625644,4.87723743914053e-80
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39147,0.0105168652372547,0.00242195055335019,0.00576984215268837,0.0152638883218211,1.41898340850607e-05
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39147,-0.0127300969655599,0.00241970058981923,-0.0174727101216056,-0.0079874838095142,1.45190555451079e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39147,-0.00862707696173167,0.00239863208473695,-0.0133283958478161,-0.00392575807564725,0.000323339003107866
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39147,-0.016158834782703,0.00245730833530482,-0.0209751591199004,-0.0113425104455055,4.99527453551848e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39147,0.00593098363635826,0.00237396395472151,0.00127801428510409,0.0105839529876124,0.0124878471495316
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39721,0.00294774825521852,0.00235357819239962,-0.00166526500188473,0.00756076151232177,0.210422972104202
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39721,-0.0333474993818829,0.00260814163729858,-0.0384594569909881,-0.0282355417727777,3.00132647530016e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39721,-0.0348315518868315,0.00259715962977706,-0.0399219847611945,-0.0297411190124684,8.64932337220409e-41
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39721,-0.0201983516960565,0.00250982048346491,-0.0251175998436477,-0.0152791035484653,9.02767126452062e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39721,0.0257225929152118,0.002538791350568,0.0207465618680985,0.030698623962325,4.72419326322003e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39909,0.0399979203321969,0.00253138145685603,0.035036412676759,0.0449594279876347,8.08985673291068e-56
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39909,-0.0161654432312304,0.00245475828952251,-0.0209767694786945,-0.0113541169837663,4.67905869662398e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39909,-0.0242846168532046,0.0025548374069634,-0.0292920981708529,-0.0192771355355564,2.2694366466467e-21
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39909,0.00700514166610731,0.00239831794696366,0.00230443849005853,0.0117058448421561,0.00349557042445853
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39909,-0.000979402015309119,0.00236233149756874,-0.00560957175054386,0.00365076771992562,0.678446681471022
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39913,-0.0174140664476886,0.00257956671668361,-0.0224700172123885,-0.0123581156829888,1.52099149388452e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39913,-0.0354661592436337,0.0026747892935121,-0.0407087462589174,-0.03022357222835,6.45258887877371e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39913,-0.0372917711680657,0.00268153366677825,-0.042547577154951,-0.0320359651811803,1.03153313153387e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39913,-0.0284840075232214,0.00263105693047815,-0.0336408791069586,-0.0233271359394842,3.21654075470713e-27
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39913,0.0320120919065706,0.0026617860823811,0.0267949911851037,0.0372291926280376,3.57879155285052e-33
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39913,-0.0433849438158233,0.00254138456254318,-0.0483660575584079,-0.0384038300732387,9.03665863937598e-65
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39913,-0.0280385937520345,0.00247275584156319,-0.0328851952014983,-0.0231919923025706,1.09069753954882e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39913,-0.0161299534293178,0.00241136808549152,-0.0208562348768811,-0.0114036719817544,2.31918085436659e-11
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39913,-0.0410022787358329,0.00256398038382182,-0.0460276802881237,-0.0359768771835422,4.03441722997948e-57
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39913,0.0330722864546076,0.00249454218568115,0.0281829837706726,0.0379615891385427,6.58703241804455e-40
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39913,0.020757145887036,0.00250386976331841,0.0158495611509319,0.0256647306231401,1.2209886814143e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39913,-0.0398328448272155,0.00262037012443634,-0.0449687702711107,-0.0346969193833202,7.96540822918313e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39913,-0.0398866185078474,0.00264993627775598,-0.0450804936122491,-0.0346927434034456,7.45595755807436e-51
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39913,-0.029078821076227,0.00239586731770568,-0.0337747210189302,-0.0243829211335239,9.44330514707134e-34
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39913,0.039741388931228,0.00259481004551444,0.0346555612420197,0.0448272166204363,1.41305646071351e-52
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39913,0.0016359962789206,0.00242073350084701,-0.00310864138273954,0.00638063394058074,0.49916043036522
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39913,-0.0380208267793207,0.00251095437167246,-0.0429422973477987,-0.0330993562108427,1.939619134056e-51
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39913,-0.0315226734945278,0.00248392304642288,-0.0363911626655166,-0.0266541843235389,9.99845159912054e-37
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39913,-0.0307519881783475,0.00246877527772702,-0.0355907877226925,-0.0259131886340025,1.8828940263561e-35
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39913,0.0498356218694925,0.00252364890425143,0.0448892700171597,0.0547819737218253,8.78196009665547e-86
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39913,-0.00748899045022043,0.00241275862275316,-0.0122179973508166,-0.00275998354962423,0.00191312091333975
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39913,-0.0567086285446098,0.00249242149118494,-0.0615937746673323,-0.0518234824218874,8.20742068716798e-113
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39913,-0.0327495804612596,0.00237032416535373,-0.037395415825353,-0.0281037450971663,3.58036791415638e-43
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39913,-0.038825569609697,0.00265907232484161,-0.0440373513663865,-0.0336137878530074,5.60507997196675e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39913,0.0568460637480054,0.00243634524946295,0.052070827059058,0.0616213004369528,1.92502761537421e-118
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39913,-0.0243291765236895,0.00238201149455135,-0.0289979190530101,-0.0196604339943688,2.044560369025e-24
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39913,-0.0362817740493867,0.00247929849111421,-0.0411411990919705,-0.0314223490068028,3.4887331112067e-48
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39913,0.0127766483120955,0.00247450031453287,0.00792662769561104,0.0176266689285799,2.45499830155389e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39913,-0.0463038389958011,0.00256894879887523,-0.0513389786415966,-0.0412686993500057,6.40699771011095e-72
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39913,0.0523671414721772,0.00238691225946411,0.0476887934436276,0.0570454895007269,3.82486403057127e-105
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39913,-0.0200609759827713,0.00244257354261941,-0.0248484201263053,-0.0152735318392373,2.31913124279221e-16
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39913,-0.0236893920933527,0.00240558662904638,-0.0284043418862836,-0.0189744423004218,8.14225976381943e-23
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39913,0.0175719641629012,0.00244715441293636,0.012775541513546,0.0223683868122565,7.24644650365151e-13
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39913,-0.0464648373719397,0.00244340134356991,-0.0512539040053367,-0.0416757707385427,9.37240251522209e-80
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39913,0.050433785933261,0.0024515780861189,0.0456286928844679,0.055238878982054,7.68738800477234e-93
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39909,0.0002432571758292,0.00272101434150906,-0.00508993093352856,0.00557644528518696,0.928765578944991
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39909,-0.0278082862376427,0.00248958867664712,-0.032687880043871,-0.0229286924314143,7.32006991879617e-29
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39909,-0.0443717896603085,0.002356984899698,-0.0489914800637166,-0.0397520992569005,3.23577218560362e-78
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39909,0.0169758250227992,0.00286685739319857,0.01135678453213,0.0225948655134684,3.25715768228964e-09
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39909,0.0458150988809142,0.00263573808340497,0.0406490522374404,0.0509811455243879,4.62220074516782e-67
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39913,0.0479213744844178,0.00265403511712446,0.0427194656548538,0.0531232833139817,3.65721953414481e-72
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39913,-0.0607033439974996,0.00268665709346212,-0.0659691919006854,-0.0554374960943139,2.6613603469425e-111
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39913,-0.0631245664830449,0.00258732285283353,-0.0681957192745986,-0.0580534136914912,4.02506031143663e-129
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39913,-0.00570368589385947,0.00268616083553765,-0.0109685611315133,-0.000438810656205685,0.0337389680225744
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39913,0.054332201028281,0.00254514247946517,0.0493437217685292,0.0593206802880327,9.99285252492166e-100
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39913,0.0462222442800553,0.00267504796177664,0.0409791502749731,0.0514653382851376,2.69111852483948e-66
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39913,-0.0538024675001728,0.00260823919816468,-0.0589146163285756,-0.04869031867177,2.49591939610846e-93
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39913,-0.0535284140281312,0.00249162336984938,-0.058411995833036,-0.0486448322232264,5.85911103502876e-101
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39913,-0.0150044599838498,0.00284740600911593,-0.0205853757617171,-0.00942354420598263,1.38550189916043e-07
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39913,0.0537776645077524,0.00253291055244594,0.0488131598249584,0.0587421691905465,1.10567722160917e-98
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39913,0.0342344898314007,0.00238735913648373,0.0295552659238926,0.0389137137389088,2.38264788453237e-46
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39913,-0.0528754965967981,0.00235605100140392,-0.0574933565595498,-0.0482576366340464,7.38702929364992e-110
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39913,-0.0516965877855197,0.00231474240940539,-0.0562334829079542,-0.0471596926630851,7.87661795937006e-109
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39913,0.00183073350229821,0.00260670308216987,-0.00327840453875474,0.00693987154335115,0.482491290850233
PLA2G15,Phospholipase A2 group XV,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39913,0.0513227435366499,0.00259723124444247,0.0462321702975426,0.0564133167757571,6.81524251502598e-86
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51773,-0.00352416072617638,0.00204029768312867,-0.00752314418510856,0.000474822732755805,0.0841288611528867
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51773,-0.00170378552369818,0.00199514848604372,-0.00561427655634388,0.00220670550894751,0.393132114461133
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49801,-0.00102234558854562,0.00191767310386895,-0.00478098487212877,0.00273629369503752,0.593956633169854
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49801,-0.000938079253789784,0.00207202393473916,-0.00499924616587853,0.00312308765829896,0.650742839269053
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49801,-0.0040527558884867,0.00206181342894133,-0.00809391020921172,-1.16015677616883e-05,0.0493523779422654
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49801,-0.00357035345016565,0.00190195849333464,-0.00729819209710154,0.000157485196770248,0.0605021189620181
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24009.Traffic intensity on the nearest road,51773,-0.099099454147131,0.0823123157870497,-0.260431593089749,0.0622326847954864,0.22862126715959
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24010.Inverse distance to the nearest road,51773,0.00243831222459551,0.00178231410067251,-0.0010550234127226,0.00593164786191362,0.171304379424269
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24011.Traffic intensity on the nearest major road,51773,-0.00102199380604179,0.00180084486288462,-0.00455164973729564,0.00250766212521206,0.570373679833582
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24012.Inverse distance to the nearest major road,51773,-0.00212541315517544,0.00182504354911009,-0.00570249851143122,0.00145167220108034,0.244198122347922
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24013.Total traffic load on major roads,51773,-0.0627159685287603,0.0568604169849753,-0.174162385819312,0.0487304487617914,0.270044857559783
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24015.Sum of road length of major roads within 100m,51773,-0.0673906992540381,0.0551036024324883,-0.175393760021715,0.040612361513639,0.221346920918639
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51773,-0.0056620093096088,0.00204419003063034,-0.00966862176964426,-0.00165539684957334,0.00561267818752109
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51773,-0.00598771232928428,0.00204337291570708,-0.00999272324407017,-0.0019827014144984,0.00338900271495177
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51773,-0.00582165211426393,0.00202246829142448,-0.00978568996545592,-0.00185761426307195,0.00399888933813323
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51724,-0.00303358937982484,0.00196139016712192,-0.0068779141073838,0.000810735347734117,0.12195837350243
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24020.Average daytime sound level of noise pollution,51773,-0.00155865148568953,0.00178697741236363,-0.00506112721392224,0.00194382424254317,0.383091585703651
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24021.Average evening sound level of noise pollution,51773,-0.00154222146732847,0.00178664409526099,-0.00504404389404001,0.00195960095938308,0.388037919627223
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24022.Average night-time sound level of noise pollution,51773,-0.00155882966746347,0.0017869923124611,-0.00506133459988722,0.00194367526496028,0.383041170372177
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51773,-0.00154314981135172,0.00178678897649334,-0.00504525620527865,0.00195895658257522,0.387790834683128
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51773,-0.00154625932154594,0.00178684817421664,-0.00504848174301055,0.00195596309991867,0.386851003725557
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2405.Number of children fathered,36316,-0.152407223387436,0.0589734139994263,-0.267995114826311,-0.0368193319485599,0.00976788922783511
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48577,0.00355710020719043,0.00211905753646787,-0.000596252564286606,0.00771045297866746,0.0932380449917497
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48577,-0.000485156381665872,0.00193427336945013,-0.00427633218578813,0.00330601942245639,0.801954589348167
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24502.Water percentage, buffer 1000m",48577,0.000524215070253416,0.0018896526925483,-0.00317950420714124,0.00422793434764808,0.781464976214685
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48577,0.00394373056278414,0.00200165001758333,2.04965283208229e-05,0.00786696459724746,0.0488220368474821
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48577,-0.0021513500549879,0.00195746195989815,-0.00598797549638828,0.00168527538641247,0.271756630713465
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24505.Water percentage, buffer 300m",48577,-0.000810480836202912,0.00189685914077814,-0.00452832475212807,0.00290736307972224,0.669182628447896
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51863,0.00219386977817765,0.00200986101519814,-0.00174545781161071,0.00613319736796601,0.275039024778897
PLA2G15,Phospholipase A2 group XV,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51863,0.00242813633976133,0.00189824132933592,-0.00129241666573709,0.00614868934525974,0.200854663435663
PLA2G15,Phospholipase A2 group XV,Working and living environment,X24508.Distance (Euclidean) to coast,51863,-0.00138058677478828,0.00181611232022158,-0.00494016692242258,0.00217899337284602,0.447148622741992
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28695,0.0889746484515099,0.097443115030814,-0.102013857008886,0.279963153911905,0.36123903887881
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2704.Years since last cervical smear test,35674,0.0659218048668834,0.0606510865626566,-0.0529543247959235,0.18479793452969,0.277102169172197
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2714.Age when periods started (menarche),39046,0.0707753402379393,0.0530276373588674,-0.0331588289854408,0.174709509461319,0.181998560682223
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2734.Number of live births,39526,0.109436848992518,0.0505492926161098,0.0103602354649426,0.208513462520093,0.0304063309582541
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2744.Birth weight of first child,35618,-0.198735205080121,0.058190497782227,-0.312788580733286,-0.0846818294269563,0.000639385873541585
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2754.Age at first live birth,33581,-0.0153222063829623,0.00288008700874627,-0.020967176920105,-0.00967723584581959,1.06045604900233e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2764.Age at last live birth,33559,-0.012364387877832,0.002881757711907,-0.0180126329931697,-0.00671614276249429,1.79942506663216e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2794.Age started oral contraceptive pill,37234,-6.05938249065941e-05,0.00287081354366063,-0.00568738837048144,0.00556620072066825,0.983160737102194
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2804.Age when last used oral contraceptive pill,36039,-0.010846407404958,0.00254250745082924,-0.0158297220085833,-0.00586309280133267,2.00486765866685e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2867.Age started smoking in former smokers,29354,-0.000251984682768886,0.00399097740338449,-0.00807430039340249,0.00757033102786472,0.949658442730093
PLA2G15,Phospholipase A2 group XV,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36558,0.275225448276455,0.0694953706499178,0.139014521802616,0.411436374750294,7.52510263264273e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36554,0.313988819450099,0.0771065054415183,0.162860068784723,0.465117570115475,4.68650341663722e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36576,0.366015625298461,0.0785410954484966,0.212075078219407,0.519956172377514,3.19141211831018e-06
PLA2G15,Phospholipase A2 group XV,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36545,0.329002401536984,0.0766720934201843,0.178725098433422,0.479279704640545,1.79163547256137e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X28739.Difficulty with standing for long periods,36588,0.515837025262345,0.07264818089095,0.373446590716083,0.658227459808607,1.30928794618502e-12
PLA2G15,Phospholipase A2 group XV,Mental health,X28740.Difficulty with taking care of household responsibilities,36611,0.464489960199235,0.0808506445523107,0.306022696876706,0.622957223521764,9.40017313978631e-09
PLA2G15,Phospholipase A2 group XV,Mental health,X28741.Difficulty learning a new task,36516,0.349336622303128,0.0911679783297702,0.170647384776778,0.528025859829478,0.00012782897084165
PLA2G15,Phospholipase A2 group XV,Mental health,X28742.Difficulty with joining in community activities,36079,0.472192341547225,0.0871285379118645,0.30142040723997,0.642964275854479,6.09038265720636e-08
PLA2G15,Phospholipase A2 group XV,Mental health,X28743.Difficulty with being emotionally affected by health problems,36524,0.41438671890632,0.0748065387791977,0.267765902899092,0.561007534913547,3.0948601971534e-08
PLA2G15,Phospholipase A2 group XV,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36610,0.510776644028604,0.10106141057223,0.312696279307033,0.708857008750175,4.38369734440601e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29200,0.273000406851837,0.0923258057689724,0.0920418275446513,0.453958986159023,0.00312085528077945
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2897.Age stopped smoking,29356,0.0309276630786751,0.0047963016301173,0.0215269118836452,0.040328414273705,1.22830594865977e-10
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35232,-0.00566730278001407,0.00548948483078224,-0.0164266930483473,0.00509208748831912,0.301910254886828
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35232,0.007828101721529,0.00589749333150244,-0.00373098520821578,0.0193871886512738,0.184415992482426
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35232,-0.00980636917428106,0.0198722830255944,-0.048756043904446,0.0291433055558839,0.621690286755857
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35232,-0.0125768714224914,0.0195303872163901,-0.0508564303666161,0.0257026875216333,0.519611594809711
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35232,0.00277817346253686,0.0210586506221317,-0.0384967817568413,0.044053128681915,0.895045535823371
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35232,-0.00690083621894955,0.0178035685143928,-0.0417958305071595,0.0279941580692604,0.698312128541513
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35232,0.00878479040410378,0.00816937100059536,-0.00722717675706313,0.0247967575652707,0.282248689900146
PLA2G15,Phospholipase A2 group XV,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35232,0.00600504576105287,0.0149730199376121,-0.0233420733166669,0.0353521648387726,0.688385137741946
PLA2G15,Phospholipase A2 group XV,Mental health,X29002.Recent lack of interest or pleasure in doing things,35159,0.269002747567698,0.080157237084415,0.111894562882244,0.426110932253151,0.000793569025833841
PLA2G15,Phospholipase A2 group XV,Mental health,X29003.Recent feelings of depression,35155,0.299221917169327,0.0777488479423033,0.146834175202412,0.451609659136241,0.000119463613507046
PLA2G15,Phospholipase A2 group XV,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35164,0.102055259828986,0.0637557976654152,-0.0229061035952275,0.2270166232532,0.109466622610716
PLA2G15,Phospholipase A2 group XV,Mental health,X29005.Recent feelings of tiredness or low energy,35171,0.256829225740759,0.0651938529730209,0.129049273913638,0.38460917756788,8.2152509573292e-05
PLA2G15,Phospholipase A2 group XV,Mental health,X29006.Recent poor appetite or overeating,35172,0.330624403450594,0.0853648330706973,0.163309330632027,0.497939476269161,0.000108076199677886
PLA2G15,Phospholipase A2 group XV,Mental health,X29007.Recent feelings of inadequacy,35136,0.107590304882949,0.0829574190363329,-0.0550062364282633,0.270186846194162,0.194680406723992
PLA2G15,Phospholipase A2 group XV,Mental health,X29008.Recent trouble concentrating on things,35169,0.243154696527256,0.0824782512633794,0.0814973240510327,0.40481206900348,0.00320380264355038
PLA2G15,Phospholipase A2 group XV,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35161,0.128896894459602,0.145148122429283,-0.155593425501794,0.413387214420997,0.374539784455554
PLA2G15,Phospholipase A2 group XV,Mental health,X29010.Recent thoughts of suicide or self-harm,35096,0.548919972650774,0.158379555332003,0.238496044200049,0.8593439011015,0.000530530923338333
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#0.Substances taken for depression_None of options listed,32720,-0.0217540397320598,0.0109987407478821,-0.0433115715979086,-0.00019650786621097,0.0479747155437934
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32720,-0.00822502260162329,0.0196316102340649,-0.0467029786603905,0.0302529334571439,0.675249447485954
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32720,-0.00672554815177833,0.0107609385806248,-0.0278169877698029,0.0143658914662462,0.531989499286932
PLA2G15,Phospholipase A2 group XV,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32720,-0.0113629749659322,0.0308522060185459,-0.0718332987622821,0.0491073488304176,0.712655753975639
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32720,-0.00580871874211341,0.0183616611444723,-0.0417975745852791,0.0301801371010522,0.751744017008929
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32720,0.0212528533393085,0.0198011790757223,-0.0175574576491072,0.0600631643277243,0.283160152623484
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32720,0.00717657821043629,0.0225260643808081,-0.0369745079759476,0.0513276643968202,0.750044968606965
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32720,0.00939018315305128,0.0277727757162626,-0.0450444572508234,0.063824823556926,0.735290206336663
PLA2G15,Phospholipase A2 group XV,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32720,0.0330116032525966,0.0220708630556305,-0.0102472883364391,0.0762704948416324,0.134764946691256
PLA2G15,Phospholipase A2 group XV,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32720,-0.0108842999565038,0.0111572875146795,-0.0327525834852755,0.010983983572268,0.329322672268092
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32720,-0.011338325113501,0.0162672627390204,-0.043222160081981,0.020545509854979,0.48581942716705
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32720,-0.0219072277671602,0.0256740182592425,-0.0722283035552754,0.0284138480209551,0.393524924327057
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32720,-0.0326319308717663,0.0318761166551457,-0.0951091195158519,0.0298452577723193,0.305999753224073
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32720,-0.000860189818400777,0.0195190658291977,-0.0391175588436284,0.0373971792068268,0.964850228597933
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32720,-0.0381654420693339,0.0328254473208772,-0.102503318818253,0.0261724346795854,0.244991280255502
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32720,-0.00962685477534683,0.0318855606411063,-0.0721225536319152,0.0528688440812216,0.762720940920747
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32720,-0.0101746699308958,0.0169649268306759,-0.0434259265190205,0.0230765866572289,0.548689962847203
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32720,0.0120875166476549,0.0166750043406853,-0.0205954918600884,0.0447705251553981,0.468539661609259
PLA2G15,Phospholipase A2 group XV,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32720,-0.024424676578861,0.023750258466919,-0.0709751831740222,0.0221258300163003,0.303791548806625
PLA2G15,Phospholipase A2 group XV,Mental health,X29058.Recent feelings or nervousness or anxiety,34994,0.234046771144077,0.0746683923957285,0.0876967220484495,0.380396820239705,0.0017260496335779
PLA2G15,Phospholipase A2 group XV,Mental health,X29059.Recent inability to stop or control worrying,35000,0.193188785964408,0.0782236699500838,0.0398703928622436,0.346507179066572,0.0135376211638849
PLA2G15,Phospholipase A2 group XV,Mental health,X29060.Recent worrying too much about different things,34990,0.199990350913566,0.0717048731150863,0.0594487996079972,0.340531902219136,0.00529484542041174
PLA2G15,Phospholipase A2 group XV,Mental health,X29061.Recent trouble relaxing,34998,0.239957806682768,0.0751715605672182,0.0926215479710208,0.387294065394516,0.00141617466329729
PLA2G15,Phospholipase A2 group XV,Mental health,X29062.Recent restlessness,35001,0.324883330302778,0.104576146970892,0.11991408223983,0.529852578365727,0.00189684630301631
PLA2G15,Phospholipase A2 group XV,Mental health,X29063.Recent easy annoyance or irritability,34985,0.207763757884596,0.0757038952595326,0.0593841231759116,0.356143392593279,0.0060713999321047
PLA2G15,Phospholipase A2 group XV,Mental health,X29064.Recent feelings of foreboding,34973,0.331913002691935,0.087035149656577,0.161324109365044,0.502501896018826,0.000137725061275156
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32720,0.00911441417495808,0.0111447813733123,-0.012729357316734,0.0309581856666502,0.413482528410845
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32720,-0.00988977907697384,0.0183445949526983,-0.0458451851842625,0.0260656270303148,0.589823580708736
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32720,0.0443529169126875,0.0239412977975872,-0.00257202677058341,0.0912778605959584,0.0639773281586353
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32720,0.0106676770223619,0.0265709712654492,-0.0414114266579186,0.0627467807026423,0.688077454752923
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#2.Symptoms of panic attack_Sweating,32720,0.00310007557217349,0.0167537392393391,-0.0297372533369312,0.0359374044812782,0.85320359826994
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32720,0.0183255089267071,0.018073480212163,-0.0170985122891324,0.0537495301425466,0.310636842549162
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32720,0.0184338770185555,0.0181103280767354,-0.0170623660118458,0.0539301200489569,0.308769701715203
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32720,0.0115018941087384,0.0163304641647808,-0.0205058156542321,0.0435096038717089,0.48125120224504
PLA2G15,Phospholipase A2 group XV,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32720,0.0140275567220115,0.0216701271533304,-0.028445892498516,0.056501005942539,0.517440137658278
PLA2G15,Phospholipase A2 group XV,Mental health,X29076.Felt loved as a child,34948,-0.104317608829429,0.0662356115021263,-0.234139407373597,0.0255041897147381,0.115297107458297
PLA2G15,Phospholipase A2 group XV,Mental health,X29077.Physically abused by family as a child,34953,-0.0300727818431803,0.0853836228736134,-0.197424682675463,0.137279118989102,0.724689086230432
PLA2G15,Phospholipase A2 group XV,Mental health,X29078.Felt hated by family member as a child,34939,0.18357144806997,0.087532840623754,0.0120070804474121,0.355135815692528,0.0360009394229162
PLA2G15,Phospholipase A2 group XV,Mental health,X29079.Sexually molested as a child,34856,0.0585662805176223,0.119941463594957,-0.176518988128493,0.293651549163737,0.625353809529298
PLA2G15,Phospholipase A2 group XV,Mental health,X29080.Someone to take to doctor when needed as a child,34934,-0.332284786508131,0.0998960394942431,-0.528081023916847,-0.136488549099414,0.000882917034346806
PLA2G15,Phospholipase A2 group XV,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34939,0.0460604691644184,0.118530903697381,-0.186260102082449,0.278381040411285,0.697583529549762
PLA2G15,Phospholipase A2 group XV,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34878,0.123883353268849,0.0941633775517534,-0.0606768667325877,0.308443573270286,0.188328528949205
PLA2G15,Phospholipase A2 group XV,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34947,0.0677590672434405,0.104415742932212,-0.136895788903694,0.272413923390575,0.51639360373493
PLA2G15,Phospholipase A2 group XV,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34910,0.147243814952157,0.148907309460557,-0.144614511590535,0.439102141494849,0.322768633739522
PLA2G15,Phospholipase A2 group XV,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34908,0.261654488338007,0.144853430143189,-0.0222582347426428,0.545567211418658,0.0708925116030397
PLA2G15,Phospholipase A2 group XV,Mental health,X29086.Experienced a violent or sexual assault,34945,0.0587860785313551,0.115651356409856,-0.167890580031962,0.285462737094672,0.611250090462279
PLA2G15,Phospholipase A2 group XV,Mental health,X29087.Experienced a life-threatening injury or illness,34954,0.38448776476965,0.0810636636663007,0.225602983983701,0.5433725455556,2.13164343109353e-06
PLA2G15,Phospholipase A2 group XV,Mental health,X29088.Experienced a marital separation or divorce,34955,0.1081985135755,0.0720754790067029,-0.0330694252776374,0.249466452428638,0.133336588115314
PLA2G15,Phospholipase A2 group XV,Mental health,X29089.Experienced the death of a spouse or partner,34965,0.0594096086801883,0.115773206872142,-0.167505876789211,0.286325094149587,0.607853057302056
PLA2G15,Phospholipase A2 group XV,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34952,0.177347137455212,0.089055248884776,0.00279884964105109,0.351895425269373,0.046458313396596
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29091.Frequency of drinking alcohol,34961,-0.0420424713380641,0.0606781282213883,-0.160971602651985,0.076886659975857,0.488401326999725
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33849,-0.0242771941816607,0.0676996941913058,-0.15696859479662,0.108414206433299,0.71990100084846
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33863,-0.0522832344313795,0.0671806138821504,-0.183957237640394,0.0793907687776353,0.436440745835578
PLA2G15,Phospholipase A2 group XV,Mental health,X29104.Ever used cannabis,34947,-0.0778366652492915,0.0793897690898681,-0.233440612665433,0.07776728216685,0.326891863477221
PLA2G15,Phospholipase A2 group XV,Mental health,X29108.Ever thought that life not worth living,34899,0.0508398324324896,0.0737015749014942,-0.093615254374439,0.195294919239418,0.490330322513816
PLA2G15,Phospholipase A2 group XV,Mental health,X29109.Ever contemplated self-harm,34920,0.0484229416756054,0.0960932765379971,-0.139919880338869,0.23676576369008,0.614330428995478
PLA2G15,Phospholipase A2 group XV,Mental health,X29111.Ever self-harmed,34937,0.166582472358115,0.150660537235059,-0.128712180622599,0.46187712533883,0.268888692994702
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34943,-0.151312293212419,0.102645067962342,-0.35249662641861,0.049872039993772,0.140474684909766
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33404,-0.0410951547288505,0.0228728905340008,-0.085926020175492,0.00373571071779111,0.0724188097593592
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33404,-0.0431729445081994,0.0177800752215708,-0.0780218919424782,-0.00832399707392061,0.0151938231511757
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33404,-0.0411188983193887,0.0185711522606873,-0.0775183567503358,-0.00471943988844156,0.0268435564084756
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33404,-0.0147397871521778,0.0249710562249186,-0.0636830573530183,0.0342034830486627,0.555020354748735
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34934,-0.0661516964192465,0.0678751817435306,-0.199187052636566,0.0668836597980735,0.329776024531457
PLA2G15,Phospholipase A2 group XV,Health and medical history,X29153.Pain or discomfort today,34949,0.254084961111387,0.065531744300365,0.125642742282672,0.382527179940103,0.000106240160821931
PLA2G15,Phospholipase A2 group XV,Mental health,X29154.Anxiety or depression today,34949,0.258910121477437,0.080015025546579,0.102080671406143,0.415739571548732,0.00121671612386095
PLA2G15,Phospholipase A2 group XV,Mental health,X29166.Frequency of confiding in someone close,34707,-0.176800722067291,0.0641851407294948,-0.302603597897101,-0.0509978462374814,0.00588721849532308
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34914,0.0156256354984602,0.00567589674932978,0.00450087786977379,0.0267503931271465,0.00591517243445019
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34914,-0.0208775814615856,0.00563772597633628,-0.0319275243752047,-0.00982763854796648,0.000213939966325925
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34914,-0.00301211024643436,0.00701524423975858,-0.0167619889563612,0.0107377684634925,0.667664961524694
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34914,-0.00477217505268535,0.00837183386931989,-0.0211809694365523,0.0116366193311816,0.56867066986084
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34914,-0.0161791460393551,0.0129472801748623,-0.0415558151820853,0.00919752310337511,0.211465816565209
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34914,-0.00737312112025184,0.0061159812318347,-0.0193604443346478,0.00461420209414417,0.228016856423629
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34913,-0.00809852573361229,0.00668502603131052,-0.0212011767549809,0.00500412528775634,0.225751696041128
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34913,-0.0133407002290738,0.00946716196307991,-0.0318963376767104,0.00521493721856281,0.158817422559811
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34913,0.0384865795603556,0.0152550712166788,0.00858663997566514,0.0683865191450461,0.0116540170308509
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34913,0.0193971662069198,0.0150044832664107,-0.0100116209952452,0.0488059534090847,0.196121782758694
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34913,-0.0154394490958952,0.0200675112284736,-0.0547717711037035,0.0238928729119131,0.441686939889126
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34913,0.0143017978601856,0.010023237680538,-0.00534374799366876,0.03394734371404,0.15364732154893
PLA2G15,Phospholipase A2 group XV,Mental health,X29171.Frequency of feeling 'in tune' with people,34728,-0.199477138344448,0.0773441567927784,-0.351071685658294,-0.0478825910306029,0.00991926996760656
PLA2G15,Phospholipase A2 group XV,Mental health,X29172.Freuency of feeling that lacks companionship,34863,0.235435451676523,0.0707567097143487,0.0967523006363995,0.374118602716647,0.000879497723867127
PLA2G15,Phospholipase A2 group XV,Mental health,X29173.Frequency of feeling left out,34819,0.175066596125038,0.0727201182433453,0.0325351643680808,0.317598027881994,0.0160828756253719
PLA2G15,Phospholipase A2 group XV,Mental health,X29174.Frequency of feeling isolated from others,34850,0.244545665710057,0.0753172798853359,0.0969237971347992,0.392167534285316,0.00117030141839821
PLA2G15,Phospholipase A2 group XV,Mental health,X29175.Tendency to bounce back quickly after hard times,34932,-0.116601953393757,0.0628056326340982,-0.239700993356589,0.00649708656907594,0.0634013996529594
PLA2G15,Phospholipase A2 group XV,Mental health,X29176.Ability to make it through stressful events,34932,0.148637049120809,0.0616978213873738,0.0277093192015567,0.269564779040062,0.0160075522830458
PLA2G15,Phospholipase A2 group XV,Mental health,X29177.Quick recovery from stressful events,34932,-0.093894375526117,0.0623200837601304,-0.216041739695973,0.0282529886437387,0.131929665748284
PLA2G15,Phospholipase A2 group XV,Mental health,X29178.Hard to snap back when something bad happens,34932,0.123004336009198,0.062240795934448,0.00101237597768021,0.244996296040716,0.048149505396987
PLA2G15,Phospholipase A2 group XV,Mental health,X29179.Comes through difficult times with little trouble,34932,-0.0591994734815483,0.0630363801050902,-0.182750778487525,0.0643518315244284,0.347683535568972
PLA2G15,Phospholipase A2 group XV,Mental health,X29180.Tendency to take a long time to get over setbacks,34932,0.0772293124189324,0.0624416129745828,-0.04515624901125,0.199614873849115,0.216178510216333
PLA2G15,Phospholipase A2 group XV,Mental health,X29181.General happiness,34863,0.154377002619669,0.0645390813329196,0.0278804032071462,0.280873602032191,0.0167738696874132
PLA2G15,Phospholipase A2 group XV,Mental health,X29182.Belief that own life is meaningful,34764,-0.244128005313315,0.0640580331040327,-0.36968175019722,-0.118574260429411,0.000139141996070129
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28895,0.0350357135509973,0.0877729152810208,-0.136999200399804,0.207070627501798,0.689789924145378
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2946.Father's age,34110,-0.00873688536885975,0.00426823841794773,-0.0171026326680373,-0.000371138069682196,0.0406881002618001
PLA2G15,Phospholipase A2 group XV,Health and medical history,X2966.Age high blood pressure diagnosed,29059,-0.00588571692828958,0.0076234581893704,-0.0208276949794556,0.0090562611228764,0.4401178837598
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30000.White blood cell (leukocyte) count,51290,0.012798740151167,0.00186557335009066,0.00914221638498929,0.0164552639173447,7.00841266197289e-12
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51290,0.00298650663596711,0.00220260681510409,-0.00133060272163689,0.00730361599357112,0.175143297348338
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30020.Haemoglobin concentration,51290,0.0098027846275625,0.0023489548409175,0.00519883313936421,0.0144067361157608,3.01204796978311e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30030.Haematocrit percentage,51290,0.00764170182058082,0.00229910092611188,0.00313546400540153,0.0121479396357601,0.000889230144179998
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30040.Mean corpuscular volume,51290,0.0053695700828519,0.00186670790833335,0.00171082258251853,0.00902831758318526,0.00402432434690273
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51289,0.00622003912905988,0.00187083518769838,0.00255320216117105,0.00988687609694871,0.000886172575767407
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51289,0.000188630765886076,0.00182264402192879,-0.00338375151709436,0.00376101304886651,0.917572518899557
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51290,0.0188205782837037,0.00177743579684202,0.0153368041218933,0.0223043524455141,3.78047425434149e-26
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30080.Platelet count,51290,0.0151851380957695,0.00188021941180512,0.0114999080486315,0.0188703681429076,6.95023071820237e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30090.Platelet crit,51290,0.0123778280731997,0.00192649635004148,0.0086018952271184,0.016153760919281,1.33990590733387e-10
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51290,-0.00982817815117927,0.00181279381246961,-0.0133812540236197,-0.00627510227873883,5.95779345019141e-08
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30110.Platelet distribution width,51290,0.00557032530640516,0.00179636615543749,0.00204944764174768,0.00909120297106263,0.00193138583800297
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30120.Lymphocyte count,51253,-0.00584959903106444,0.00190005096999263,-0.00957369893225,-0.00212549912987888,0.00208143728013554
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30130.Monocyte count,51253,0.0250531437204287,0.00188739938986119,0.0213538409163007,0.0287524465245566,4.36393275151019e-40
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30140.Neutrophill count,51253,0.0132721795280724,0.00184736763289473,0.00965133896759876,0.0168930200885461,6.92401223594734e-13
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30150.Eosinophill count,51253,0.00539912335678643,0.00181440025856733,0.00184289884999447,0.0089553478635784,0.00292569238932152
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30160.Basophill count,51253,0.172781695483034,0.0415083652164354,0.0914252996588212,0.254138091307248,3.15639227681781e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30170.Nucleated red blood cell count,51253,0.122419016686918,0.186751702427235,-0.243614320070464,0.488452353444299,0.51214010200386
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30180.Lymphocyte percentage,51253,-0.0183130218401797,0.00186013624845148,-0.0219588888871446,-0.0146671547932148,7.86184743496338e-23
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30190.Monocyte percentage,51253,0.0180110124925278,0.00186585724273239,0.0143539322967723,0.0216680926882833,5.17821546414718e-22
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30200.Neutrophill percentage,51253,0.00913276510941039,0.00183532590848166,0.00553552632878634,0.0127300038900344,6.52710365849391e-07
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30210.Eosinophill percentage,51253,0.00145419748734939,0.00179068257639677,-0.00205554036238828,0.00496393533708706,0.416746383143218
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30220.Basophill percentage,51253,0.00269590632353406,0.00178135836038541,-0.000795556062821351,0.00618736870988947,0.130189824096791
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30230.Nucleated red blood cell percentage,51252,0.120757685274742,0.187127275248183,-0.246011774211698,0.487527144761181,0.518722774529083
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30240.Reticulocyte percentage,50802,0.0299277183532279,0.00190652819661721,0.0261909230878582,0.0336645136185977,2.76691518342057e-55
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30250.Reticulocyte count,50802,0.0308555705357491,0.00195433788351864,0.0270250682840525,0.0346860727874456,6.67907394489622e-56
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30260.Mean reticulocyte volume,50802,0.0137092922534614,0.00185181183063053,0.0100797410654255,0.0173388434414972,1.36854456246736e-13
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30270.Mean sphered cell volume,50802,0.00570141735080196,0.00185980410351148,0.00205620130791947,0.00934663339368446,0.00217447912987887
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30280.Immature reticulocyte fraction,50802,0.0252882149246554,0.00192532416544041,0.0215145795603922,0.0290618502889186,2.75768590717605e-39
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50802,0.0339429094130276,0.0019481023763592,0.0301246287553636,0.0377611900706916,1.28431851831385e-67
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30300.High light scatter reticulocyte count,50802,0.0350465978671702,0.00198098031496353,0.0311638764498417,0.0389293192844987,1.20778410751052e-69
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30500.Microalbumin in urine,32046,0.0289580448216146,0.00349754411171532,0.0221028583626526,0.0358132312805766,1.43216625016099e-16
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51410,-0.00401234333097624,0.0019100794139004,-0.00775609898222101,-0.000268587679731457,0.0356837549715045
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30520.Potassium in urine,51347,-0.000773287477539751,0.00177044778163663,-0.00424336512954755,0.00269679017446805,0.662277901684226
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30530.Sodium in urine,51350,-6.93793873130993e-05,0.00183998147784489,-0.00367574308388909,0.00353698430926289,0.96992191275281
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30600.Albumin,48604,-0.0117744096064079,0.00198302299335484,-0.0156611346733834,-0.0078876845394324,2.93071183032393e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30610.Alkaline phosphatase,50887,0.0309570726506993,0.00186660897596673,0.0272985190578045,0.034615626243594,1.81212464958111e-61
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30620.Alanine aminotransferase,50878,0.0551785886794034,0.00195358343131033,0.0513495651540352,0.0590076122047716,5.39140422280146e-173
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30630.Apolipoprotein A,48469,-0.012405710198063,0.00216182143157221,-0.0166428802039445,-0.00816854019218144,9.6613910230636e-09
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30640.Apolipoprotein B,50724,0.000221237028618129,0.00190464474201934,-0.00351186666573978,0.00395434072297604,0.90752931227225
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30650.Aspartate aminotransferase,50796,0.0596176933630202,0.00182341850146351,0.0560437931001517,0.0631915936258887,5.66265719646745e-230
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30660.Direct bilirubin,46684,0.00998022690780571,0.00206121598694511,0.00594024357339329,0.0140202102422181,1.29436919339862e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30670.Urea,50878,-0.0523720308426076,0.0019270156230024,-0.0561489814636923,-0.0485950802215229,1.71509003618228e-160
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30680.Calcium,48599,-2.51769427321828e-05,0.00193298917009946,-0.00381383571612712,0.00376348183066276,0.989608052019529
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30690.Cholesterol,50892,-0.0078639465530952,0.00195718348079014,-0.0117000261754439,-0.00402786693074652,5.88551247910669e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30700.Creatinine,50881,-0.0339225868250334,0.00235476846916173,-0.0385379330245904,-0.0293072406254765,7.08814641148543e-47
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30710.C-reactive protein,50808,0.0386139517229645,0.00202084694018165,0.0346530917202085,0.0425748117257205,7.4558198398665e-81
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30720.Cystatin C,50885,0.0517770620117637,0.00216089035547078,0.047541716915041,0.0560124071084864,1.45065924243974e-125
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30730.Gamma glutamyltransferase,50877,0.055930750149996,0.0019892257826728,0.0520318676159573,0.0598296326840347,1.79932249888788e-171
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30740.Glucose,48565,0.0195565158817495,0.00196494196530302,0.0157052296297556,0.0234078021337434,2.71468857350338e-23
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50656,0.0168952242780071,0.00197540249732418,0.0130234353832517,0.0207670131727625,1.26446613706869e-17
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30760.HDL cholesterol,48583,-0.0310616246857901,0.00228120262209085,-0.0355327818250882,-0.0265904675464921,4.54244222247441e-42
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30770.IGF-1,50765,-0.0467902323934165,0.00190744430846279,-0.0505288232380035,-0.0430516415488294,1.95234754025429e-131
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30780.LDL direct,50833,-0.00808742408589553,0.0019361669592865,-0.0118823113260971,-0.004292536845694,2.96270393920916e-05
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30790.Lipoprotein A,45497,-0.0133732077358609,0.00202377305376153,-0.0173398029212335,-0.00940661255048828,3.9845658913467e-11
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30810.Phosphate,48536,-0.00871183216976914,0.00193155792857985,-0.0124976857097856,-0.00492597862975264,6.50458315762826e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30830.SHBG,48352,0.0260962745658056,0.00223986548487687,0.0217061382154469,0.0304864109161642,2.74847487338497e-31
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30840.Total bilirubin,50785,-0.00181893373309016,0.00189784726902281,-0.00553871438037487,0.00190084691419454,0.337859897790564
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30850.Testosterone,48715,0.0142470538027144,0.00319715739314102,0.00798062531215796,0.0205134822932707,8.38039580147158e-06
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30860.Total protein,48583,0.0284308187906073,0.00195441093724496,0.0246001733536072,0.0322614642276074,9.61306394036196e-48
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30870.Triglycerides,50868,0.0308754378678803,0.00194122613367459,0.0270706346458781,0.0346802410898825,1.05688181204985e-56
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30880.Urate,50856,0.00609225182219484,0.00234763200746085,0.00149089308757158,0.0106936105568181,0.00946248667000094
PLA2G15,Phospholipase A2 group XV,Blood and urine assays,X30890.Vitamin D,49794,-0.0288750001349048,0.00202334163638811,-0.0328407497422254,-0.0249092505275841,4.96168926122637e-46
PLA2G15,Phospholipase A2 group XV,Physical measures,X3137.Number of measurements made,49915,0.084360487456192,0.0474158551672483,-0.00857458867161474,0.177295563583999,0.0752248624316091
PLA2G15,Phospholipase A2 group XV,Physical measures,X3143.Ankle spacing width,39923,0.0151727307777895,0.00331193724656651,0.00868133377451909,0.0216641277810598,4.65735349217394e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39922,-0.0110846877342038,0.00254258811215648,-0.0160681604340305,-0.00610121503437712,1.31105722868962e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X3146.Speed of sound through heel,39923,-0.0135684021695764,0.00247084827566986,-0.0184112647898894,-0.00872553954926352,4.04824166025506e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39923,-0.0132083177775169,0.00249453054795797,-0.0180975976515145,-0.00831903790351925,1.20641857883226e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,X3148.Heel bone mineral density (BMD),39913,-0.0131757282178983,0.00249809926806281,-0.0180720027833014,-0.00827945365249522,1.34991866543382e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3526.Mother's age at death,35323,-0.00481587125031599,0.00340408157982253,-0.0114878711467681,0.00185612864613617,0.157173551954101
PLA2G15,Phospholipase A2 group XV,Health and medical history,X3581.Age at menopause (last menstrual period),30402,-0.0143072516642195,0.00443522731549419,-0.0230002972025881,-0.00561420612585087,0.00126229510411822
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30353,-0.00137577890496746,0.00408683695399813,-0.00938597933480378,0.00663442152486887,0.736401739940176
PLA2G15,Phospholipase A2 group XV,Physical measures,X4100.Ankle spacing width (left),32809,0.0124240360137129,0.00442456566868172,0.00375188730309672,0.021096184724329,0.00499632299378258
PLA2G15,Phospholipase A2 group XV,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32808,-0.0134556634289058,0.00340712845974765,-0.0201336352100112,-0.00677769164780039,7.89918248313562e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,X4103.Speed of sound through heel (left),32809,-0.0200256868542181,0.00332147935228276,-0.0265357863846923,-0.0135155873237439,1.71351550541005e-09
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32809,-0.0183721950581603,0.00335196415420406,-0.0249420448004002,-0.0118023453159204,4.34362156159514e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4105.Heel bone mineral density (BMD) (left),32801,-0.0175057045604421,0.00336015239487498,-0.0240916032543971,-0.0109198058664872,1.93264601067224e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32809,-0.0183722602384062,0.00335200096051986,-0.0249421821210252,-0.0118023383557873,4.3446186307829e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4119.Ankle spacing width (right),32801,0.0155691168241316,0.00434337902404068,0.00705609393701189,0.0240821397112513,0.000339441432320405
PLA2G15,Phospholipase A2 group XV,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32801,-0.0111416416969306,0.00343523630220501,-0.0178747048492524,-0.00440857854460877,0.00118570515079515
PLA2G15,Phospholipase A2 group XV,Physical measures,X4122.Speed of sound through heel (right),32801,-0.016737097509455,0.00334075190116228,-0.0232849712357331,-0.010189223783177,5.54780535035368e-07
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32801,-0.0152376864449566,0.00337415978610321,-0.0218510396257189,-0.0086243332641943,6.38278094174497e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4124.Heel bone mineral density (BMD) (right),32791,-0.0145537639752722,0.00338653247933729,-0.0211913676347733,-0.0079161603157711,1.74534321023952e-05
PLA2G15,Phospholipase A2 group XV,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32801,-0.0152380410849884,0.00337416644849007,-0.0218514073240289,-0.00862467484594788,6.37989055760621e-06
PLA2G15,Phospholipase A2 group XV,Physical measures,X4194.Pulse rate,33103,0.0398236733851265,0.00319516888677975,0.0335611423670382,0.0460862044032148,2.26421298342301e-35
PLA2G15,Phospholipase A2 group XV,Physical measures,X4195.Pulse wave reflection index,33103,-0.0101586193363734,0.00314975506293337,-0.0163321392597228,-0.00398509941302397,0.0012631841083498
PLA2G15,Phospholipase A2 group XV,Physical measures,X4196.Pulse wave peak to peak time,33098,-0.0185459057198721,0.00337700828305554,-0.0251648419546609,-0.0119269694850832,4.08372385588022e-08
PLA2G15,Phospholipase A2 group XV,Physical measures,X4198.Position of the pulse wave peak,33103,0.0232352959958922,0.0032392568826667,0.0168863525058655,0.029584239485919,7.89956010544556e-13
PLA2G15,Phospholipase A2 group XV,Physical measures,X4199.Position of pulse wave notch,33103,0.02541636303262,0.00317757115762907,0.0191883235636671,0.031644402501573,1.40897988792572e-15
PLA2G15,Phospholipase A2 group XV,Physical measures,X4200.Position of the shoulder on the pulse waveform,33103,0.0276503363830346,0.00331471338191692,0.0211534981544775,0.0341471746115918,8.3735316591862e-17
PLA2G15,Phospholipase A2 group XV,Physical measures,X4269.Number of triplets attempted (left),32967,0.0578056298616743,0.219761639192585,-0.372927182955792,0.488538442679141,0.792527362775497
PLA2G15,Phospholipase A2 group XV,Physical measures,X4270.Volume level set by participant (left),32881,0.0113431566452336,0.0653443618829642,-0.116731792645376,0.139418105935843,0.862191240534765
PLA2G15,Phospholipase A2 group XV,Physical measures,X4276.Number of triplets attempted (right),32976,0.0112960981626056,0.214025526932653,-0.408193934625394,0.430786130950605,0.957908984806576
PLA2G15,Phospholipase A2 group XV,Physical measures,X4277.Volume level set by participant (right),32877,0.0495937927258557,0.0652562464764093,-0.0783084503679064,0.177496035819618,0.447283205007819
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4288.Time to answer,33139,-0.00443206008533258,0.00362966979658325,-0.0115462128866358,0.00268209271597059,0.222092713192222
PLA2G15,Phospholipase A2 group XV,Cognitive function,X4290.Duration screen displayed,33139,-0.000639298573991985,0.00324622937700997,-0.00700190815293153,0.00572331100494756,0.843882140606333
PLA2G15,Phospholipase A2 group XV,Physical measures,X46.Hand grip strength (left),52115,-0.0259982859487201,0.00254007976350232,-0.0309768422851846,-0.0210197296122555,1.52178877223052e-24
PLA2G15,Phospholipase A2 group XV,Physical measures,X47.Hand grip strength (right),52093,-0.0243590538643038,0.0025142600317349,-0.0292870035265042,-0.0194311042021034,3.65873148160324e-22
PLA2G15,Phospholipase A2 group XV,Physical measures,X48.Waist circumference,52173,0.04476537648372,0.00398501975667224,0.0369547377606424,0.0525760152067976,3.22237870475018e-29
PLA2G15,Phospholipase A2 group XV,Health and medical history,X4803.Tinnitus,32923,-0.0798459403918374,0.0797569877809554,-0.23616963644251,0.0764777556588352,0.316797807735379
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4825.Noisy workplace,33059,0.203696713837486,0.0867368192079285,0.0336925481899463,0.373700879485026,0.0188730032397059
PLA2G15,Phospholipase A2 group XV,Working and living environment,X4836.Loud music exposure frequency,32997,0.0389725001029387,0.0939229289472339,-0.14511644063364,0.223061440839517,0.678194636163404
PLA2G15,Phospholipase A2 group XV,Physical measures,X49.Hip circumference,52169,-0.0234370017813566,0.00314569552203191,-0.0296025650045392,-0.0172714385581741,9.56423531187968e-14
PLA2G15,Phospholipase A2 group XV,Physical measures,X50.Standing height,52145,-0.000203338056450167,0.00250094759962932,-0.00510519535172364,0.0046985192388233,0.935200446187782
PLA2G15,Phospholipase A2 group XV,Health and medical history,X5057.Number of older siblings,32261,-0.068698427335709,0.067739487688605,-0.201467823205375,0.0640709685339568,0.310537393128227
PLA2G15,Phospholipase A2 group XV,Physical measures,X51.Seated height,52005,0.000530932681350682,0.00231844510428871,-0.00401321972305518,0.00507508508575655,0.818867645860414
PLA2G15,Phospholipase A2 group XV,Eye measures,X5181.Ever had eye surgery,30132,-0.16214866788219,0.176104030493043,-0.507312567648555,0.183015231884174,0.35721377413673
PLA2G15,Phospholipase A2 group XV,Eye measures,X5186.Duration visual-acuity screen displayed (right),30118,0.00176741882978017,0.00388458290685856,-0.00584636366766262,0.00938120132722295,0.649137317789769
PLA2G15,Phospholipase A2 group XV,Eye measures,X5188.Duration visual-acuity screen displayed (left),30116,0.00208265830436649,0.00385439584920595,-0.00547195756007718,0.00963727416881016,0.588986454348841
PLA2G15,Phospholipase A2 group XV,Eye measures,X5190.Duration at which refractometer first shown (right),30062,-0.000847516886613589,0.00380507640655642,-0.00830546664346416,0.00661043287023699,0.823750486487878
PLA2G15,Phospholipase A2 group XV,Eye measures,X5193.Duration at which refractometer first shown (left),30060,0.000755336433334213,0.00381878890175172,-0.00672948981409915,0.00824016268076758,0.843212130632966
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5199.logMAR, initial (right)",30094,0.0794194130556764,0.0818784650694443,-0.0810623784804344,0.239901204591787,0.332100554223778
PLA2G15,Phospholipase A2 group XV,Eye measures,X5200.Final number of letters displayed (right),30094,0.506472614228749,0.641002206775646,-0.749891711051517,1.76283693950902,0.429484154986139
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5201.logMAR, final (right)",30040,0.0103993675842733,0.00368954049750239,0.00316786820916863,0.017630866959378,0.00483857628150117
PLA2G15,Phospholipase A2 group XV,Eye measures,X5202.Number of rounds to result (right),30094,-0.16504245626454,0.0790492936872458,-0.319979071891541,-0.0101058406375379,0.0368526310210461
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5206.logMAR, initial (left)",30090,0.18909631510953,0.0818175998298018,0.0287338194431183,0.349458810775941,0.0208546475285017
PLA2G15,Phospholipase A2 group XV,Eye measures,X5207.Final number of letters displayed (left),30090,-0.384672621738449,0.545917761928817,-1.45467143511893,0.685326191642032,0.481063919542256
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5208.logMAR, final (left)",30041,0.00968253269151942,0.00369593061905879,0.0024385086781642,0.0169265567048746,0.00882010479492037
PLA2G15,Phospholipase A2 group XV,Eye measures,X5209.Number of rounds to result (left),30086,0.0442159482707935,0.0785737431698164,-0.109788588342047,0.198220484883634,0.573637786590987
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29848,0.00810750071946898,0.00383393159607249,0.000592994791166905,0.0156220066477711,0.0344992781315828
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29848,0.0122420859279509,0.00376750795703866,0.00485777033215509,0.0196264015237466,0.00116293244113743
PLA2G15,Phospholipase A2 group XV,Eye measures,X5256.Corneal hysteresis (right),29848,0.00276826968097143,0.00387165712289972,-0.00482017827991202,0.0103567176418549,0.474631358139553
PLA2G15,Phospholipase A2 group XV,Eye measures,X5257.Corneal resistance factor (right),29848,0.00926059686485412,0.00379917160560974,0.00181422051785904,0.0167069732118492,0.0148168689453169
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29827,0.00302870810116804,0.00387497251442581,-0.00456623802710655,0.0106236542294426,0.434476209426559
PLA2G15,Phospholipase A2 group XV,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29827,0.00837917716284153,0.00378400932478156,0.000962518886269677,0.0157958354394134,0.0268413448698617
PLA2G15,Phospholipase A2 group XV,Eye measures,X5264.Corneal hysteresis (left),29827,0.00935889708055442,0.00386039272398564,0.00179252734154256,0.0169252668195663,0.0153658345963871
PLA2G15,Phospholipase A2 group XV,Eye measures,X5265.Corneal resistance factor (left),29827,0.0120763338743603,0.00378325605149141,0.00466115201343712,0.0194915157352834,0.00142000964275842
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29922,0.0313401278622593,0.310723213435146,-0.577677370470627,0.640357626195145,0.919663439194741
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52074,0.0428214948674263,0.0108692319298594,0.0215178002849018,0.0641251894499507,8.17804223989861e-05
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52074,0.00939412437217788,0.012151042355797,-0.0144219186451843,0.0332101673895401,0.439462200992484
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52074,0.0222827620986962,0.0287273470862167,-0.0340228381902886,0.078588362387681,0.437954043397776
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52074,-0.00935656830350132,0.00501820454410474,-0.0191922492099466,0.000479112602943966,0.0622583765724148
PLA2G15,Phospholipase A2 group XV,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52074,-0.00371292602492554,0.00449867541214802,-0.0125303298327357,0.00510447778288458,0.409186921660219
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",37902,-0.0149126356873143,0.0051387476237587,-0.0249845810298814,-0.00484069034474726,0.00371367216383357
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",37902,-0.00860288135420461,0.0181757770788103,-0.0442274044286727,0.0270216417202635,0.635995292843831
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",37902,-0.00273791737885461,0.00874112571698805,-0.0198705237841512,0.014394689026442,0.754116266160714
PLA2G15,Phospholipase A2 group XV,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",37902,0.0137921711759524,0.00554912381671304,0.00291588849519486,0.02466845385671,0.0129496590566212
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52158,0.0194226353324176,0.0101564130246272,-0.000483934195851826,0.039329204860687,0.0558411634723446
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52158,0.0194226353324176,0.0101564130246272,-0.000483934195851826,0.039329204860687,0.0558411634723446
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52158,-0.00487154938766639,0.00744410679491132,-0.0194619987056926,0.0097188999303598,0.512848559494212
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52158,-0.0196029637111244,0.0115730703247096,-0.0422861815475552,0.00308025412530629,0.0903061329656729
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52158,-0.00225813565152893,0.0283608322654931,-0.0578453668918954,0.0533290955888376,0.93653875576256
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52158,0.0162533154055097,0.0199926064487536,-0.0229321932340473,0.0554388240450667,0.416244216255491
PLA2G15,Phospholipase A2 group XV,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52158,0.101998629537109,0.0304995832617609,0.0422194463440574,0.16177781273016,0.000826085704547856
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52073,0.0132561425495383,0.00570310688369033,0.00207805305750529,0.0244342320415714,0.0201126215392555
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52073,0.0257217835986581,0.009836185665942,0.00644285969341177,0.0450007075039044,0.00892707092597898
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52073,0.00718950441966005,0.00479555738065174,-0.00220978804641736,0.0165887968857375,0.133832684720936
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52073,0.0382257327233944,0.00903043018219103,0.0205260895663,0.0559253758804888,2.31332132604662e-05
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52073,0.0295652216241664,0.00783616591827481,0.0142063364243477,0.044924106823985,0.000161678232458255
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52073,0.049120504453908,0.00637949720515534,0.0366166899318035,0.0616243189760124,1.40791169223537e-14
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30094,0.0281469534481297,0.0179813918465957,-0.00709657457119785,0.0633904814674573,0.117554466775763
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30094,0.00851010429055863,0.0156898002932924,-0.0222419042842944,0.0392621128654117,0.587564272428318
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30094,0.0374129166538421,0.0196339808643064,-0.00106968584019847,0.0758955191478828,0.0567586435829655
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30094,-0.0100622955794626,0.0161711032674873,-0.0417576579837378,0.0216330668248125,0.533807301084373
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52025,0.04249315092137,0.0158257280607534,0.0114747239222933,0.0735115779204466,0.00725575786570981
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52025,0.00170137092245639,0.0229273714870819,-0.0432362771922242,0.046639019037137,0.940846221520579
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52025,0.107029527649507,0.0469925506483573,0.0149241283787271,0.199134926920288,0.0227587761899861
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52025,0.0537821216154246,0.0404449596831429,-0.0254899993635356,0.133054242594385,0.183607866955891
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52025,0.0216334894327701,0.0147221798918751,-0.00722198315530519,0.0504889620208453,0.141722271321497
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52025,0.0151886864813679,0.0186123918089414,-0.0212916014641571,0.051668974426893,0.414477084149512
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52025,0.00885417959548889,0.00767092227878574,-0.00618082807093116,0.023889187261909,0.248406544666423
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33610,0.0256427952808338,0.0143772452052236,-0.00253660532140435,0.053822195883072,0.0745249751145449
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33610,0.0830121116512943,0.0163511182760357,0.0509639198302644,0.115060303472324,3.90840385083653e-07
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33610,0.0258189080582307,0.0209395393732177,-0.015222589113276,0.0668604052297374,0.217597366621672
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33610,-0.000204344083727859,0.0062196353153379,-0.0123948293017902,0.0119861411343344,0.973791151577968
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35765,0.000623142945301583,0.00711264282765699,-0.0133176369969061,0.0145639228875093,0.930187646095728
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35765,-0.0157867992913834,0.00574292822032747,-0.0270429386032253,-0.00453065997954159,0.00598837290260145
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35765,-0.00367821864858107,0.00568751657342872,-0.0148257511325014,0.00746931383533923,0.51782701812684
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35766,0.00270492335644007,0.0138144703071981,-0.0243714384456682,0.0297812851585483,0.84476721458396
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35766,0.0661352752153423,0.00902954790122448,0.0484373613289423,0.0838331891017423,2.5559813739111e-13
PLA2G15,Phospholipase A2 group XV,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35766,0.00600013596702509,0.0112832908288945,-0.0161151140576082,0.0281153859916584,0.594893972181463
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52073,-0.0189225052805717,0.0133459919183555,-0.0450806494405485,0.00723563887940516,0.156247999898361
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52073,0.0207778118741892,0.0087002941435142,0.00372523535290133,0.037830388395477,0.0169388828012748
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52073,-0.0301668746819028,0.0262178594206901,-0.0815538791464555,0.0212201297826499,0.249897077469632
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52073,-0.00592852002284329,0.00986427300945345,-0.0252624951213721,0.0134054550756855,0.547838606475401
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52073,-0.0224360134347147,0.0107912403774313,-0.04358684457448,-0.00128518229494927,0.0376176350860426
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52073,0.0396448579216044,0.011917043741025,0.0162874521891954,0.0630022636540133,0.000879817974842123
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52073,0.00596210772015498,0.00384296142586562,-0.00157009667454162,0.0134943121148516,0.120808511492537
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28103,0.0431125990703896,0.0128540836981177,0.0179185950220789,0.0683066031187003,0.000803509939920406
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28103,0.0777814329502744,0.016224595664149,0.0459812254485423,0.109581640452006,1.6904884040595e-06
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28103,-0.0588787716234901,0.0119196971907414,-0.0822413781173432,-0.0355161651296369,8.12878492165356e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28103,0.000795411924472744,0.00991903036615032,-0.0186458875931819,0.0202367114421274,0.936089534006174
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52210,0.0149274419134282,0.00411824947755453,0.00685567293742131,0.0229992108894351,0.000289796944795637
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52210,0.0430223228619078,0.0121207169268909,0.0192657176852016,0.0667789280386139,0.000386607373596579
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52210,0.0101088738725283,0.00415555393128536,0.00196398816720898,0.0182537595778476,0.0149962635871463
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52210,0.00929942001515596,0.00404251691032726,0.00137608687091453,0.0172227531593974,0.0214325959112652
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52210,0.0496562831082713,0.00583644884198169,0.0382168433779872,0.0610957228385554,1.85609154129216e-17
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52210,0.0125365988939468,0.00601506617784642,0.000747069185367807,0.0243261286025258,0.0371509399092838
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52210,0.00615785052288546,0.0044499863047763,-0.00256412263447609,0.014879823680247,0.166433386788123
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52210,0.0638067478781491,0.0126238002078996,0.0390640994706657,0.0885493962856324,4.34246797960164e-07
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43035,-0.035077417029938,0.00436389004394582,-0.0436306415160719,-0.0265241925438042,9.64893278906314e-16
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43035,0.0182782556087825,0.00459173347054412,0.00927845800651599,0.0272780532110489,6.89693538856442e-05
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43035,0.00816148443399013,0.00549534128675574,-0.00260938448805112,0.0189323533560314,0.137516757958827
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43036,-0.0129555627875584,0.0075356848494001,-0.0277255050923826,0.00181437951726582,0.0855889444864737
PLA2G15,Phospholipase A2 group XV,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43036,-0.0092636848981757,0.00485090457249036,-0.0187714578602568,0.000244088063905407,0.0561890818128248
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51966,-0.0137900618189557,0.0045538566938646,-0.0227156209389303,-0.00486450269898107,0.00246225231143727
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51966,-0.00770647589162733,0.00357197886538598,-0.0147075544677838,-0.000705397315470816,0.0309766668075682
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51966,0.0112974861628832,0.00426454693071102,0.0029389741786896,0.0196559981470768,0.00807361735023925
PLA2G15,Phospholipase A2 group XV,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51966,-0.0403097596348298,0.00662576836156423,-0.0532962656234957,-0.0273232536461639,1.18892029894831e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51982,-0.0228508502390321,0.00391898770074539,-0.030532066132493,-0.0151696343455711,5.57634046535218e-09
PLA2G15,Phospholipase A2 group XV,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51982,-0.046738193317785,0.00536343500418363,-0.0572505259259849,-0.0362258607095851,3.08531227125823e-18
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52073,-0.0200623079027779,0.00414392071349549,-0.028184392501229,-0.0119402233043267,1.29620327215277e-06
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52073,-0.0278025111597516,0.00509445128565977,-0.0377876356796447,-0.0178173866398584,4.87192302712967e-08
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52073,-0.0096536640058054,0.00765201995832733,-0.024651623124127,0.00534429511251617,0.207109038186565
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52073,-0.0290848826284774,0.008940108323256,-0.0466074949420591,-0.0115622703148956,0.00114205843768298
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52073,0.0151848000945869,0.00879337824824989,-0.0020502212719829,0.0324198214611567,0.0842064740622586
PLA2G15,Phospholipase A2 group XV,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52073,-0.041346624229112,0.0126166530033107,-0.066075264115601,-0.016617984342623,0.00104988489596318
PLA2G15,Phospholipase A2 group XV,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39923,-0.0132081014535612,0.00249454617905769,-0.0180974119645143,-0.00831879094260816,1.20720898400906e-07
PLA2G15,Phospholipase A2 group XV,Physical activities,X864.Number of days or week walked 10+ minutes,51686,-0.0530837192476671,0.0368795642002704,-0.125367665080197,0.0192002265848628,0.150054045867288
PLA2G15,Phospholipase A2 group XV,Physical activities,X874.Duration of walks,48031,-0.00122424454402247,0.0018556267676988,-0.00486127300871211,0.00241278392066717,0.509422364619788
PLA2G15,Phospholipase A2 group XV,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50953,-0.157389242938437,0.0361828566495098,-0.228307641971476,-0.0864708439053973,1.36741234585692e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X894.Duration of moderate activity,44829,-0.0703360390356888,0.0435992235036651,-0.155790517102872,0.0151184390314948,0.106707286765715
PLA2G15,Phospholipase A2 group XV,Physical activities,X90087.No-wear time bias adjusted average acceleration,30327,-0.0148907608073069,0.00365599676445814,-0.0220565144656449,-0.00772500714896896,4.69721614349006e-05
PLA2G15,Phospholipase A2 group XV,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50964,-0.400545884390346,0.0374362152924312,-0.473920866363511,-0.32717090241718,1.15780128007801e-26
PLA2G15,Phospholipase A2 group XV,Physical activities,X914.Duration of vigorous activity,39873,-0.00634961637950839,0.00232367437719298,-0.0109040181588066,-0.00179521460021015,0.00629101351851519
